NYUCI In The News, 2011

December 2011

Forbes.com

December 15
Environmental Risks for Breast Cancer: What You Need To Know – By Alice G. Walton
By the end of 2011, about 230,000 cases of breast cancer will have been diagnosed in the United States. We know there’s a genetic component to breast cancer, but as we’re also understanding more and more, there’s a decided environmental role to it. The Institute of Medicine (IOM) has just released a large-scale report reviewing the evidence for the role of certain lifestyle variables and environmental factors in breast cancer risk. Robert J. Schneider, PhD, is quoted.
-Robert J. Schneider, PhD, the Albert B. Sabin Professor of Microbiology and Molecular Pathogenesis, Department of Microbiology and professor, Department of Radiation Oncology
Read more: forbes.com

News-Medical.com

December 14
NYUCI Experts Present Latest Research Findings about Hematologic Cancers at 53rd ASH Meeting
Experts from the NYU Cancer Institute presented their latest research findings about hematologic cancers at the 53rd ASH Annual Meeting and Exposition held Dec. 10-13, 2011.
-NYU Cancer Institute
Read more: news-medical.net

Genetic Engineering & Biotechnology News

December 9
New Genome Center to Bring Sequencing, Bioinformatics Muscle to Big Apple – By Alex Philippidis
If New York City is ever to become a top-tier biopharma cluster, the $125 million New York Genome Center (NYGC) set to start operations in spring will be one way to achieve this. NYGC unites 11 academic medical centers that have the shared goal of developing one of North America’s largest genomics facilities.
-NYU School of Medicine
Read more: genengnews.com

U.S. News & World Report

Syndicated HealthDay article also appeared on Yahoo! News, Health.MSN.com, iVillage.com, HealthFinder.gov, TimesofIndia.com, ZeeNews.india.com
December 7
Expert Panel Pinpoints Environmental Culprits in Breast Cancer - By Maureen Salamon, HealthDay News
Women can lower their risk of developing breast cancer by avoiding unnecessary medical radiation, forgoing menopausal hormone therapy and limiting alcohol use, but they don't need to worry about using hair dyes or cell phones, a broad new national report says. Robert Schneider, PhD, is quoted.
-Robert J. Schneider, PhD, the Albert B. Sabin Professor of Microbiology and Molecular Pathogenesis, Department of Microbiology and professor, Department of Radiation Oncology
Read more: health.usnews.com, consumer.healthday.com

ABCNews.com

December 7
Hormones and Weight Among Biggest Breast Cancer Risks, Says New Report - By Kim Carollo
A new report by the Institute of Medicine found that some environmental exposures play a well-established role in raising breast cancer risk, while others -- such as certain chemicals -- have no impact at all, drawing its conclusions from previous research. Robert Schneider, PhD, is quoted.
-Robert J. Schneider, PhD, the Albert B. Sabin Professor of Microbiology and Molecular Pathogenesis, Department of Microbiology and professor, Department of Radiation Oncology
Read more: abcnews.go.com

NBC Today Show

December 4
Brave Battle: Guiliana Rancic’s Fight Against Breast Cancer - By Ann Curry
Kathie-Ann Joseph, MD, is interviewed along with Giuliana Rancic about mastectomies and breast reconstruction.
-Kathie-Ann Joseph, MD, assistant professor, Department of Surgery
View segment: http://scoop.today.msnbc.msn.com/_news/2011/12/05/9221432-giuliana-ranci...

November 2011

Oncology Times

November 25
Need Major Commitment
From a business standpoint, gearing up for genomic cancer medicine of the future requires a major commitment on the part of cancer centers—even though whole genome sequencing is not ready for prime time right now, said speakers at the AACI meeting. William L. Carroll, MD, comments on the advantages of establishing an in-house genomic medicine program.
-William L. Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Departments of Pediatrics and Pathology
Read more: journals.lww.com

NationalCancerInstitute.gov

November 15
Searching for Clues to Obesity among the Body's Many Microbes – By Edward R. Winstead
Using new genomic tools, researchers have been systematically identifying many of the microbes living in and on our bodies. In the coming months, NCI will be sending DNA samples from patients with oral cancer to Richard Hayes, PhD, and Zhiheng Pei, MD, PhD, to sequence microbial DNA to explore associations between the mouth microbiome and cancer.
-Richard B. Hayes, DDS, PhD, MPH, professor, Department of Environmental Medicine, Division of Epidemiology
-Zhiheng Pei, MD, PhD, associate professor, Departments of Pathology and Medicine, Division of Infectious Disease and Immunology
Read more: cancer.gov

U.S. News & World Report

Syndicated article also appeared on Drugs.com, WISTV.com (Columbia, SC), KFVS.com (CBS Carbondale, IL), Health.MSN.com
November 9
More Evidence That HPV Vaccine Shields Against Cervical Cancer – By Robert Preidt, HealthDay News
A new study suggests that the Cervarix cervical cancer vaccine may provide "excellent" protection against a precancerous lesion that is often a forerunner to invasive cervical cancer. Stephanie V. Blank, MD, comments on the new study.
-Stephanie V. Blank, MD, assistant professor, Department of Obstetrics and Gynecology, Clinical Cancer Center
Read more: consumer.healthday.com, health.usnews.com, kfvs12.com, health.msn.com

Health.com

Syndicated HealthDay article also appeared on Philly.com, Health.msn.com, BioPortfolio.com, NewsDay.com, Bio-Medicine.org, iVillage.com
Additional coverage also appeared onTechnorati.com
November 3
Too Much Sitting Raises Odds for Cancer: Study - By Steven Reinberg, HealthDay News
The hours Americans spend sitting may be increasing their risk for cancer, just as the time they spend exercising can reduce the risk, according to new research. Freya Schnabel, MD, is quoted.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: consumer.healthday.com

WBNS CBS Eyewitness News at 5:00 (Columbus, OH)

CBS newspath segment also appeared on local CBS new stations across the country
November 3
Sitting & Cancer
New research shows a lack of exercise may trigger biological mechanisms that raise cancer risks. There are 49,000 cases of breast cancer and 43,000 cases of colon cancer in the U.S. each year. Only 31 percent of Americans say they get regular exercise each week. Freya Schnabel, MD, is interviewed and urges individuals to make even minor adjustments in their lifestyle.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Video Unavailable

WBNS CBS Eyewitness News at 5:00 (Columbus, OH)

Health.com

News 14 (Raleigh Durham)

November 1
Addressing Drug Shortages
The number of reported drug shortages annually has tripled from 61 in 2005 to 178 in 2010 to more than 240 this year. Medicines like Adderol for ADHD and Doxil, the last line of defense for defense for ovarian cancer patients are in short supply. James Speyer, MD, is interviewed.
-James Speyer, MD, professor, Department of Medicine, Division of Medical Oncology
Video unavailable

ABC News

November 1
Alcohol May Boost Breast Cancer Risk ... Slightly - By Dr. Mirjana Jojic
A new study in the Journal of the American Medical Association suggests women who consume as few as three to six glasses of alcohol per week may modestly increase their risk for breast cancer. Deborah Axelrod, MD, comments on study.
-Deborah Axelrod, MD, associate professor, Department of Surgery
Read more: abcnews.go.com

U.S. News & World Report

Syndicated HealthDay News article also appeared on Yahoo! News, Health.MSN.com, NewsDay.com, iVillage.com, HealthFinder.gov
November 1
Obama Acts to Ease U.S. Drug Shortages – By Amanda Gardner, HealthDay News
An executive order signed by President Barack Obama Monday may help ease the drug shortages that threaten the lives of patients across the United States. The executive order directs the FDA to "take action" to prevent and reduce the worsening drug shortages that have plagued the country for several years. James Speyer, MD, comments on how this executive order may help the national drug shortages.
-James Speyer, MD, professor, Department of Medicine, Division of Medical Oncology
Read more: consumer.healthday.com

The Associated Press

Syndicated article also appeared on HuffingtonPost.com, WashingtonPost.com, CBSNews.com, ABCNews.com, NewsDay.com, NWITimes.com, NewsPressNow.com, DenverPost.com, JournalGazette.net, Kentucky.com, TheOlympian.com, CharolotteObserver.com, Inforum.com, SMDailyJournal.com, KRLA870.com (Las Angeles Radio Station), TheNewsTribune.com, Syracuse.com, 560Wind.com (Illinois Radio Station), Brandenton.com, MarcoNews.com, TownHall.com, RoadRunner.com, CentreDaily.com, MiamiHerald.com, FresnoBee.com
November 1
New Effort to Reduce Drug Shortages a Small Step – By Lauran Neergaard
Unprecedented drug shortages are threatening the lives of cancer patients and other seriously ill people, and the Obama administration's plan to tackle them is but a small step toward solving a complex problem. President Barack Obama ordered the FDA on Monday to take new steps to send out early warnings about looming shortages and try to avert them. James Speyer, MD, is quoted.
-James Speyer, MD, professor, Department of Medicine, Division of Medical Oncology
Read more: huffingtonpost.com, cbsnews.com

The Associated Press

October 2011

The Wall Street Journal

October 31
Cancer Center Slated For East Side Tower - By Eliot Brown
Related Companies has struck a deal to build a home for an elaborate $240 million cancer-treatment center on East 92nd Street topped by a 35-story apartment tower. The group seeking to build the proton facility, New York Proton Center, is a nonprofit corporation backed by a consortium of local hospitals including NYU Langone Medical Center.
-NYU Langone Medical Center
Link is unavailable.

U.S. News & World Report

Also appeared on onespot.wsj.com
October 28
Survey of Top Doctors Finds Widespread Support for PSA Screening - By Steve Sternberg
In an exclusive new survey of Top Doctors conducted by U.S. News & World Report, virtually all responding urologists and more than 60 percent of internal-medicine specialists rejected the recent proposal by a high-level government advisory committee to end routine PSA testing, which is meant to catch prostate cancer early. Samir S. Taneja, MD, is quoted.
-Samir Taneja, MD, the James M. Neissa and Janet Riha Neissa Professor of Urologic Oncology, Departments of Radiology and Urology
Read more: health.usnews.com, onespot.wsj.com

ABCNews.com

Also appeared on ABC News Radio Online, Inquisitr.com
October 27
Study: 'The Pill' Slashes Ovarian Cancer Risk
Women who take the pill for 10 years nearly halve their risk of developing ovarian cancer, according to a large study that followed about 300,000 European women for an average of nine years. The study, published this week in the British Journal of Cancer, confirmed findings of previous studies. James Speyer, MD, comments on findings.
-James Speyer, MD, professor, Department of Medicine, Division of Medical Oncology
Read more: abcnews.go.com, abcnewsradioonline.com

MedicalNewsToday.com

Also appeared on News-Medical.net, Bio-Medicine.org, MedicalXPress.com
October 24
The Microbiome and Its Possible Role in Cancers
In the journal Cell Host and Microbe, Claudia Plottel, MD, and Martin J. Blaser, MD, present a model for understanding how cancer evolves in humans based on an understanding of the bacteria living in our body, the microbiome.
-Claudia Plottel, MD, clinical associate professor, Department of Medicine
-Martin J. Blaser, MD, the Frederick H. King Professor of Internal Medicine and chair, Department of Medicine and professor, Department of Microbiology
Read more: medicalnewstoday.com, news-medical.net, bio-medicine.org, medicalxpress.com

BioCompare.com

October 24
Preventing Cancer Development Inside the Cell Cycle
A cell cycle-regulated mechanism is behind the transformation of normal cells into cancerous cells, say researchers from the NYU Cancer Institute. Senior study author Michele Pagano, MD, is quoted.
-Michele Pagano, MD, the May Ellen and Gerald Jay Ritter Professor of Oncology, Department of Pathology
-NYU Cancer Institute
Read more: biocompare.com

News-Medical.net

Also appeared on MedIndia.net, Sify.com, ScienceDaily.com, Bio-Medicine.org, MedicalXPress.com, MachinesLikeUs.com, Biocetera.com, BioScholar.com, ScienceCodex.com, TruthDive.com
October 23
Researchers Shed Light on Preventing Cancer Development Inside the Cell Cycle - By Kathy Jones
A cell cycle-regulated mechanism is behind the transformation of normal cells into cancerous cells, say researchers from the NYU Cancer Institute. Senior study author Michele Pagano, MD, is quoted.
-Michele Pagano, MD, the May Ellen and Gerald Jay Ritter Professor of Oncology, Department of Pathology
-NYU Cancer Institute
Read more: sciencedaily.com, bio-medicine.org

BioQuickNews.com

Also appeared on RxPGNews.com
October 22
CK1 Enzyme May Be New Target for the Treatment of Cancer
Researchers from NYU Cancer Institute and collaborators have identified a cell cycle-regulated mechanism behind the transformation of normal cells into cancerous cells. The study shows the significant role that protein networks can play in a cell leading to the development of cancer. Senior study author Michele Pagano, MD, is quoted.
-Michele Pagano, MD, the May Ellen and Gerald Jay Ritter Professor of Oncology, Department of Pathology
Read more: bioquicknews.com, rxpgnews.com

eCancertv.com

October 20
Effects of Radiotherapy on the Immune System
Through the combination of radiotherapy and standard treatment in a completely new way, Silvia Formenti, MD, discusses the possibilities of using radiation to help the immune system to recognize tumors in their development.
-Silvia C. Formenti, MD, the Sandra and Edward H. Meyer Professor of Radiation Oncology and chair, Department of Radiation Oncology
View video: ecancermedicalscience.com

The Korea Herald.com

October 20
Quest for Cancer Vaccine
A few weeks ago, the Mayo Clinic made an intriguing announcement: One of its scientists had discovered a possible way to prevent ovarian and breast cancer with vaccines. And Mayo was ready to start testing them in people. Sylvia Adams, MD, is quoted.
-Sylvia Adams, MD, assistant professor, Department of Medicine, Division of Medical Oncology
Read more: koreaherald.com

The Huffington Post

October 18
40 Years and Still Waiting? – By Nancy Davis
In 1971, President Richard M. Nixon declared a war on cancer by signing into law the National Cancer Act. That was 40 years ago. A little over a decade later the Susan G. Komen Breast Cancer Foundation was established in hopes of speedy research and a cure. The Stage IV movement began in 2007 and 2008 when the National Breast Cancer Network (NBCN) along with the Young Survival Coalition (YSC) and NYU Cancer Institute met with Mayor Michael Bloomberg, who declared Oct. 13 Metastatic Breast Cancer Awareness Day.
-NYU Cancer Institute
Read more: huffingtonpost.com

The Wall Street Journal

October 18
Painting the Town Pink to Raise Millions - By Marshall Heyman
The ninth annual Avon Walk for Breast Cancer, which took place this weekend in New York, was big business. The trek itself—39.3 miles with many of the 3,500 participants—raised $8.4 million. The Avon Foundation awarded $9.1 million in grants at the closing ceremony at Hudson River Park's Pier 84 to 10 organizations, among them NYU Cancer Institute.
-NYU Cancer Institute
Read more: online.wsj.com

NY1

Also appeared on NY1.com
October 17
New York Living Health and Fitness Report - By Kafi Drexel
James Speyer, MD, is interviewed about commonly used cancer drugs that NYU Langone ran out of over the course of the summer due to the national drug shortage.
-James Speyer, MD, professor, Department of Medicine, Division of Medical Oncology, Clinical Cancer Center
View segment: ny1.com

New York Daily News

Also appeared on NYDailyNews.com
October 17
Twin Sisters Both Test Positive for Potentially Deadly Breast Cancer Gene - By Kathleen Lucadamo
The early diagnosis of twin sisters at NYU Langone Medical Center led the sisters to get tested for BRCA-1, a so-called breast cancer gene. Both tested positive. Freya Schnabel, MD, is featured and comments on a recent study that found women with BRCA are getting cancer earlier than previous generations: The average age is now 42, down from 48.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: nydailynews.com

NewsMaxHealth.com

Also appeared on ThirdAge.com
October 14
Infections After Prostate Biopsy Rise
Serious infections after prostate biopsies appear to be on the rise in the U.S., possibly fueled by antibiotic-resistant bacteria, a new study of elderly men suggests. Stacy Loeb, MD, and Herbert Lepor, MD, comment on findings.
-Herbert Lepor, MD, professor and Martin Spatz Chairman, Department of Urology and professor, Department of Pharmacology
-Stacy Loeb, MD, clinical instructor, Department of Urology
Read more: newsmaxhealth.com, thirdage.com

CBS Evening News

Also appeared on CBSNews.com
October 13
"Gray Market" Companies Exploit, Profit From Short Supply of Life-Saving Drugs - By Armen Keteyian
A record drug shortage has opened the door for so-called gray market companies that exploit the short supply. They buy up drugs for everything from cancer to infections, stockpile them then sell them to hospitals at massive markups. According to a recent report, the markup on average is 650 percent. James Speyer, MD, comments on the gray market.
-James Speyer, MD, professor, Department of Medicine
Read more: cbsnews.com

Reuters

Also appeared on Yahoo! News, WTAQ.com, BioPortfolio.com, WGNRadio.com, 929WLMI.com, OrlandoSentinel.com
October 13
Infections After Prostate Biopsy On The Rise - By Frederik Joelving
Serious infections after prostate biopsies appear to be on the rise in the U.S., possibly fueled by antibiotic-resistant bacteria, a new study of elderly men suggests. Stacy Loeb, MD, and Herbert Lepor, MD, comment on findings.
-Herbert Lepor, MD, professor and Martin Spatz Chairman, Department of Urology and professor, Department of Pharmacology
-Stacy Loeb, MD, clinical instructor, Department of Urology
Read more: in.reuters.com, news.yahoo.com, wtaq.com, bioportfolio.com, wgnradio.com, 929wlmi.com, orlandosentinel.com

Madame Noire

October 13
She's the Boss: Episode 9 – Dr. Kathie-Ann Joseph, Oncological Surgeon & Assistant Professor Of Surgery - By Madame Noire
Kathie-Ann Joseph, MD, is raising health awareness and saving lives one patient at a time. Joseph’s life-long dream of becoming a doctor coupled with her unwavering work ethic have lead her to become one of New York City’s leading surgeons in fighting breast cancer. Dr. Joseph has positioned herself as an advocate for women and tells us how she shaped her career from childhood to present day.
-Kathie-Ann Joseph, MD, assistant professor, Department of Surgery
Read more: madamenoire.com

New York Post

Also appeared on NYPost.com
October 12
Health Special: A Harsh Truth - Breast Cancer More Deadly for African-Americans - By Rachel Brumman Bender
Overall, even though Caucasian women are slightly more likely to develop breast cancer than African-Americans, according to the American Cancer Society, African-American women are more likely to die of the disease. Kathie-Ann Joseph, MD, is featured.
-Kathie-Ann Joseph, MD, assistant professor, Department of Surgery
Read more: nypost.com

CBSNews.com

October 10
Prostate Cancer Experts Bash Panel's PSA Test Recommendation - By Ryan Jaslow
Prostate cancer specialists are pushing back against an expert panel's recommendation that healthy men shouldn't get PSA blood tests for detecting prostate cancer. Herbert Lepor, MD, is quoted.
-Herbert Lepor, MD, professor and Martin Spatz Chairman, Department of Urology and professor, Department of Pharmacology
Read more: cbsnews.com

REUTERS

Also appeared on TVNZ.co.nz, huliq.com, Chicago Tribune, CNBC.com, canbecure.com, USNewsNow.info, Health-News-Today.com, MSNBC.com, TodayWorldNews.org, Bioportfolio.com
October 10
PSA Test For Prostate Cancer Not Recommended: Panel - By Julie Steenhuysen
Doctors criticized proposals by a government-backed panel recommending against prostate cancer screening in healthy men – saying they went too far and may put some men at risk of the deadly cancer. Herbert Lepor, MD, notes that a Scandinavian study with 14 years of follow up showed screening cut prostate cancer deaths by 50 percent.
-Herbert Lepor, MD, professor and Martin Spatz Chairman, Department of Urology and professor, Department of Pharmacology
Read more: chicagotribune.com, usnewsnow.info, msnbc.msn.com

WNBC (NBC)

Also appears in WPIX, WNYW (FOX), NY1, WCBS 880 AM Radio, 1010 WINS AM Radio
October 9
Senator Schumer calls FTC to Investigate Gray Market Drugs
At a press conference on Sunday, October 9th, Senator Charles Schumer called upon the FTC to launch an investigation into "gray market" drug resellers that are marking up medications in short-supply and reselling them to hospitals at exorbitant prices. The conference was held in response to a recent report by Premier healthcare alliance that uncovered the practice. Senator Schumer shared the floor with William Carroll, MD, whom he praised for important work being done at NYU Cancer Institute and for NYU Langone’s efforts to make the public aware of this important issue.
-William L. Carroll, the Julie and Edward J. Minskoff Professor of Pediatrics, Departments of Pediatrics and Pathology
View segment, 1010 WINS, WCBS 88 AM, NY1 WPIX

WNBC (NBC)

New York Post

October 8
Rudy Rips ‘Prostate Test’ Panel A New One - By Carl Campanile
Prostate-cancer survivor Rudy Giuliani yesterday blasted a government-backed panel’s advice to abandon routine prostate screening, joining a chorus of MDs decrying the recommendation as shoddy and dangerous. Herbert Lepor, MD, also comments.
-Herbert Lepor, MD, professor and Martin Spatz Chairman, Department of Urology and professor, Department of Pharmacology
Read more: nypost.com

WREG-CBS (Memphis, TN)

Also appeared on WTKR-CBS (Norfolk VA), WPRI-CBS (Providence, RI), WTVH-CBS (Syracuse), WVLT-CBS (Knoxville, TN), KFVS-CBS (Paducah, KY), KGBT-CBS (Harlingen, TX), WSBT-CBS (South Bend, IN), KZTV-CBS (Corpus Christi, TX), KRCG-CBS (Columbia, MO)
October 7
Health News: PSA Screening Test Controversy - By Randal Pinkston
Government panel recommends PSA does not save lives and can lead to unnecessary treatments. Herbert Lepor, MD, offers concern of eliminating test.
-Herbert Lepor, MD, professor and Martin Spatz Chairman, Department of Urology and professor, Department of Pharmacology

REUTERS

Also picked up in more than 25 publications, including Yahoo!News, Montreal Gazette, Ottawa Citizen, HealthNews, Reuters India, KPLR-TV (St. Louis), Star News Daily
October 7
PSA Test For Prostate Cancer Not Recommended: Panel - By Julie Steenhuysen
Doctors criticized proposals by a government-backed panel recommending against prostate cancer screening in healthy men – saying they went too far and may put some men at risk of the deadly cancer. Herbert Lepor, MD, notes that a Scandinavian study with 14 years of follow up showed screening cut prostate cancer deaths by 50 percent.
-Herbert Lepor, MD, professor and Martin Spatz Chairman, Department of Urology and professor, Department of Pharmacology
Read more: reuters.com

ABC World News Tonight With Diane Sawyer

October 7
Government Panel Downplays PSA Screening – By Sharyn Alfonsi
Federal government panel points to statistics to say prostate cancer screening is unnecessary. Dr. Herbert Lepor is interviewed.
-Herbert Lepor, MD, professor and Martin Spatz Chairman, Department of Urology and professor, Department of Pharmacology

REUTERS

ABC Eyewitness News at 4 and 5

October 7
Government Panel Discounts Prostate Cancer Screening – By MJ Birkhead
Hebert Lepor, MD, discusses the dangers of a recent government panel recommendation that PSA screening is unnecessary.
-Herbert Lepor, MD, professor and Martin Spatz Chairman, Department of Urology and professor, Department of Pharmacology
View segment

WREG-CBS (Memphis, TN)

Also appeared on WTKR-CBS (Norfolk VA), WPRI-CBS (Providence, RI), WTVH-CBS (Syracuse), WVLT-CBS (Knoxville, TN), KFVS-CBS (Paducah, KY), KGBT-CBS (Harlingen, TX), WSBT-CBS (South Bend, IN), KZTV-CBS (Corpus Christi, TX), KRCG-CBS (Columbia, MO)
October 7
Health News: PSA Screening Test Controversy - By Randal Pinkston
Government panel recommends PSA does not save lives and can lead to unnecessary treatments. Herbert Lepor, MD, offers concern of eliminating test.
-Herbert Lepor, MD, professor and Martin Spatz Chairman, Department of Urology and professor, Department of Pharmacology

WCBS 2 News at 5:00 P.M.

October 6
Steve Jobs and Pancreatic Cancer
Segment examines the progression of Steve Jobs’s pancreatic cancer. Leon Pachter, MD, and Lewis Teperman, MD, are interviewed.
-H. Leon Pachter, MD, the George David Stewart Professor of Surgery and Chair, Department of Surgery
-Lewis Teperman, MD, associate professor and vice chair, Department of Surgery

Fox Good Day New York

October 6
Pancreatic Cancer Not Typically Diagnosed Early
Roshini Raj, MD, explains pancreatic cancer and the form Steve Jobs had.
-Roshini Rajapaksa, MD, assistant professor, Department of Medicine, Division of Gastroenterology

PanachePRIVÉE

October 6
NYU Cancer Institute 2011 Gala
NYU Cancer Institute at NYU Langone Medical Center, an NCI-designated cancer center, raised $3.2 million in unrestricted funds at its annual gala on October 3, 2011. The event took place at the Plaza Hotel in Manhattan and honored Robert H. Benmosche, president and chief executive officer, American International Group, Inc. and Abraham Chachoua, MD, the Jay and Isabel Fine Associate Professor of Oncology, for their contributions to cancer research. Article highlights photographs taken at the event.
-Robert I. Grossman, MD, dean and CEO
-Kenneth G. Langone, chair, Board of Trustees
-Abraham Chachoua, MD, the Jay and Isabel Fine Associate Professor of Oncology, Departments of Medicine and Urology
-William L. Carroll, the Julie and Edward J. Minskoff Professor of Pediatrics, Departments of Pediatrics and Pathology
-Silvia C. Formenti, MD, the Sandra and Edward H. Meyer Professor of Radiation Oncology and chair, Department of Radiation Oncology
-Trustees Larry and Lori Fink, Sandy and Ed Meyer, Laura Perlmutter, Stanley Shopkorn
Read more: panacheprivee.com

IBTimes.com

October 6
Scientists Warn of Danger of Filtered Sunlight - By Vittorio Hernandez
British scientists warned on Thursday exposure to filtered sunlight is still dangerous. They said sunlight at the break and end of the day still places people at the risk of acquiring skin cancer. Darrel Rigel, MD, is quoted.
-Darrell Rigel, MD, clinical professor, Ronald O. Perelman Department of Dermatology
Read more: ibtimes.com

Bloomberg Businessweek

Also appeared on Bloomberg.com
October 4
Scene Last Night: Staley, Langone, Julianne Moore, Billy Crudup - By Amanda Gordon
Article and photos recap NYU Langone Medical Center’s 2011 Cancer Institute Gala held at the Plaza Hotel Monday night. More than 600 guests attended the event and $3.2 million was raised. The event honored Robert H. Benmosche, president and chief executive officer, American International Group, Inc. and Abraham Chachoua, MD, for their contributions to cancer research. William Carroll, MD, director of NYU Cancer Institute, presented at the event.
-Abraham Chachoua, MD, the Jay and Isabel Fine Associate Professor of Oncology, Departments of Medicine and Urology
-William L. Carroll, the Julie and Edward J. Minskoff Professor of Pediatrics, Departments of Pediatrics and Pathology
Read more: businessweek.com

New York Social Diary

October 4
Old Fashioned Cocktail Parties and Galas Dinners – By Anne Watt
This past Monday night, the NYU Cancer Institute at NYU Langone Medical Center held its annual gala at the Plaza Hotel in Manhattan in support of the Cancer Institute’s progress in the fight against cancer on all levels: patient care, research, education, and prevention. Robert H. Benmosche, president and chief executive officer, American International Group, Inc. and Abraham Chachoua, MD, were both honored for their contributions to cancer research. Over 600 guests attended the event and $3.2 million dollars was raised in support of the NYU Cancer Institute.
-Robert I. Grossman, MD, dean and CEO
-Abraham Chachoua, MD, the Jay and Isabel Fine Associate Professor of Oncology, Departments of Medicine and Urology
-William L. Carroll, the Julie and Edward J. Minskoff Professor of Pediatrics, Departments of Pediatrics and Pathology
-Lori Fink, chair of the NYU Cancer Institute Advisory Board, trustee
Read more: newyorksocialdiary.com

The New York Times

October 3
Screening: Increased Risks After Prostate Biopsy - By Nicholas Bakalar
New research has found prostate biopsy more than doubles the risk of being hospitalized for infections and other medical problems within the following month. Lead researcher Stacy Loeb, MD, is quoted.
-Stacy Loeb, MD, clinical instructor, Department of Urology
Read more: nytimes.com

FoxNews.com

October 3
Breast Cancer: What You Must Know Now – By Suza Scalora
Thanks to the billions of dollars raised for research, the war against breast cancer is beginning to be won. Freya Schnabel, MD, and Silvia Formenti, MD, are featured.
-Silvia C. Formenti, MD, the Sandra and Edward H. Meyer Professor of Radiation Oncology and chair, Department of Radiation Oncology
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: foxnews.com

EMaxHealth.com

October 3
Twenty Five Years of Advances in Breast Cancer Research - By Denise Reynolds, RD
This year celebrates 25 years of awareness, education and empowerment with National Breast Cancer Awareness Month. Although the estimate is that one in every eight women will develop breast cancer at some point in her lifetime, the exciting news is that survival rates from the disease are increasing and there have been great advances in research to help one day cure the disease for good. Freya Schnabel, MD, is quoted.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: emaxhealth.com

Health.com

Also appeared on HuffingtonPost.com, MSN.com
October 1
Breast Cancer: What You Must Know Now – By Suza Scalora
Thanks to the billions of dollars raised for research, the war against breast cancer is beginning to be won. Freya Schnabel, MD, and Silvia Formenti, MD, are featured.
-Silvia C. Formenti, MD, the Sandra and Edward H. Meyer Professor of Radiation Oncology and chair, Department of Radiation Oncology
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: health.com, huffingtonpost.com, health.msn.com

The Los Angeles Times.com

October 1
Breast Cancer: Pollution Link Remains Hazy - By Jill U. Adams
Circumstantial evidence keeps patients, doctors, advocates and scientist if environmental pollutants contribute to breast cancer, but so far no clear relationship between has been shown in people. Amber A. Guth, MD, is quoted.
-Amber A. Guth, MD, associate professor, Department of Surgery
Read more: latimes.com

Health Magazine

October 2011 Issue
Breast Cancer: What You Must Know Now – By Aviva Patz
According to Freya Schnabel, MD, we are starting to win the war on breast cancer and the progress we’ve made over the last 20 years has changed the face of the disease for American women. Breast cancer is diagnosed earlier, treated more effectively, and there is reduced recurrence and enhanced survival. Silvia Formenti, MD, discusses recent research that shows using half as many radiation treatments for breast cancer is just as effective as the full regimen, which can make a big difference in women’s quality of life.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
-Silvia C. Formenti, MD, the Sandra and Edward H. Meyer Professor of Radiation Oncology and chair, Department of Radiation Oncology
No web link available. Issue on newsstands September 23.

Essence Magazine

October 2011
The Black Woman’s Guide to Breast Cancer
Kathie-Ann Joseph, MD, discusses what African-American women need to know about breast cancer. She discussed how maintaining a lower BMI can reduce the incidence of breast cancer and the importance of acting fast when you find a lump. It might mean that you don’t have to go through an aggressive form of treatment if your breast cancer is detected early.
-Kathie-Ann Joseph, MD, assistant professor, Department of Surgery
No web link available, pg. 161 of October 2011 print edition

September 2011

BendBulletin.com

Also appeared on West Hawaii Today, Herald-Review.com
September 30
Scientists Crusade for Cancer Vaccine - By Maura Lerner
The Mayo Clinic made an announcement a few weeks ago that they had discovered a possible way to prevent ovarian and breast cancer with vaccines and was ready to begin clinical trials. Within days, the word spread around the globe and hundreds of women were suddenly vying for a few dozen spots in the clinical trials in Minnesota. Sylvia Adams, MD, is quoted.
-Sylvia Adams, MD, assistant professor, Department of Medicine, Division of Medical Oncology
Read more: bendbulletin.com, westhawaiitoday.com, herald-review.com

MedicalXpress.com

Also appeared on MininaDailyNews.com, Polk County Democrat, WentacheeWorld.com, BellinghamHerald.com
September 29
Cancer Vaccine Quest Begins at Mayo Clinic - By Maura Lerner
A few weeks ago, the Mayo Clinic announced one of its scientists had discovered a possible way to prevent ovarian and breast cancer with vaccines. Sylvia Adams, MD, provides comments.
-Sylvia Adams, MD, assistant professor, Department of Medicine, Division of Medical Oncology
Read more: medicalxpress.com, bellinghamherald.com

Your News Now.com

September 28
Healthy Living: Doctors Find New Generation of Women Gets Hereditary Cancers at Younger Age
Freya Schnabel, MD, appears in segment and comments on a new U.S. study that says women with hereditary cancers are developing them almost eight years earlier than their mothers and grandmothers. The report in the journal Cancer said women are at a greater risk of developing breast or ovarian cancer if they carry the BRCA gene.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: capitalregion.ynn.com

Huffington Post

September 27
Wanda Sykes' DCIS Breast Cancer Diagnosis: What Is It? – By Jessica Cumberbatch Anderson
Article focuses on comedienne Wanda Sykes and her battle with breast cancer. She named ductal carcinoma in situ, or DCIS, as the basis of her diagnosis, a type of breast cancer she described as "basically stage-zero cancer," in an interview on the "Ellen DeGeneres Show" yesterday. Kathie-Ann Joseph, MD, comments.
-Kathie-Ann Joseph, MD, assistant professor, Department of Surgery
Read more: huffingtonpost.com

ABCNews.com

September 26
U.S. Drug Shortage Could Threaten U.S. Health System - By Jane E. Allen
A growing shortage of important chemotherapy drugs, anesthetics and antibiotics, which has compromised or delayed care for some U.S. patients and may have led to at least 15 deaths, represents a "pressing public health problem," a top federal health official said today. James L. Speyer, MD, comments on measures NYU Langone Medical is taking to prepare for the national drug shortage.
-James Speyer, MD, professor, Department of Medicine
Read more: abcnews.go.com

Nature.com

September 26
Spotlight on Cancer Research
Article focuses on advances in gene sequencing and targeted drug development helping to make personalized healthcare a reality, and explains what it means for research careers in oncology. Anna Pavlick, DO, and Hearn Jay Cho, MD, PhD, are included.
-NYU Cancer Institute
-Anna C. Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and the Department of Medicine, Division of Medical Oncology
-Hearn Jay Cho, MD, PhD, assistant professor, Departments of Medicine and Pathology
Read more: nature.com

Bronx Net Television

September 22
Right Now on Open: Breast Cancer Awareness
Kathie-Ann Joseph, MD, of NYU Cancer Institute discusses how the burden of breast cancer often falls on African-American women with a higher mortality rate from the disease than other women. African-Americans are more likely to develop an aggressive form of breast cancer called Triple-Negative. Dr. Joseph also discussed the NYU Cancer Institute’s upcoming community event Breast Cancer in Women of Color on Saturday, September 24, 2011 from 8:30am–1:00pm.
-Kathie-Ann Joseph, MD, assistant professor, Department of Surgery
Watch more: bronxnet.org
More information about Breast Cancer in Women of Color Event: cancer.med.nyu.edu

Your News Now

September 21
Healthy Living: IUDs May Reduce Cervical Cancer Risk, Study Finds - By Marcie Fraser
Discussion about women who use IUD’s and a new study that points to lower risk of developing cervical cancer. Steven Goldstein, MD, comments on study.
-Steven Goldstein, MD, professor, Department of Obstetrics and Gynecology
Read more: hudsonvalley.ynn.com

NY1 News All Weekend

September 18
IUDs and Cervical Cancer
Discussion about women who use IUD’s and a new study that points to lower risk of developing cervical cancer. Steven Goldstein, MD, is interviewed and provides preventative tips.
-Steven Goldstein, MD, professor, Department of Obstetrics and Gynecology
View segment

CBS 2 New York

September 16
Race for the Cure – With Max Gomez
Max Gomez discusses benefit of screening and state of breast cancer research, treatment and awareness. Ruth Oratz, MD, comments.
-Ruth Oratz, MD, clinical associate professor, Department of Medicine
Watch more: newyork.cbslocal.com

WebMD

September 15
Suspicious Mammogram Result: Now What? - By Jen Uscher
Sylvia Adams, MD, is featured in article where several doctors share their tips to help women prepare for follow-up mammogram appointments. According to the American Cancer Society, about 10 percent of women who have a mammogram will be called back for more tests.
-Sylvia Adams, MD, assistant professor, Department of Medicine, Division of Oncology
Read more: webmd.com

CBS 2 News

Segment also appeared on CBS 2 News in the Morning in NY; CBS 2 at 11:00PM in NY; KUTV-CBS in Salt Lake City; WKRC-CBS CINCINNATI, OH; WBNS-CBS COLUMBUS, OH; WAWS-FOX JACKSONVILLE, FL; WFRV-CBS GREEN BAY-APPLETON, WI; KFVS-CBS PADUCAH, K; CAPE GIRARDEAU, MO; WTVH-CBS SYRACUSE, NY; KWTX-CBS WACO-TEMPLE-BRYAN, TX; KFSM-CBS FT. SMITH-FAYETTEVILLE-SPRINGDALE-ROGERS, AR; WBTW-CBS FLORENCE-MYRTLE BEACH, SC; WSHM-CBS SPRINGFIELD-HOLYOKE, MA; WWTV-CBS TRAVERSE CITY-CADILLAC, MI; KLFY-CBS LAFAYETTE, LA; WCBI-CBS COLUMBUS-TUPELO-WEST POINT, MS; WSAW-CBS WAUSAU-RHINELANDER, WI; KPSP-CBS PALM SPRINGS, CA; KOAM-CBS JOPLIN, MO; KMEG-CBS SIOUX CITY, IA; WLFI-CBS LAFAYETTE, IN
September 12 & 13
Breast Cancer Gene
A new study of women with the gene called “BRCA” shows that each subsequent generation of carriers seems to get breast cancer earlier than the last. The age of diagnosis moved down by about 8 years from one generation to the next and women with this gene are much more likely to get breast cancer in the first place. Dr. Freya Schnabel and her breast cancer survivor patient with the BRCA gene Kelly McSpirit are quoted.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: wifr.com

WABC First at 4

Also appeared on ABClocal.go.com
Additional coverage also appeared on Fox 30 News at 10:00 PM, CBS 5:00 PM News, CW News on 6 at 9:00, WIFR.com, International Business Times, CBS Minnesota
September 12
Breast Cancer Study – Dr. Sapna Parikh
Freya Schnabel, MD, appears in segment and comments on a new U.S. study that says women with hereditary cancers are developing them almost eight years earlier than their mothers and grandmothers. The report in the journal Cancer said women are at a greater risk of developing breast or ovarian cancer if they carry the BRCA gene.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
More: View WABC segment, wifr.com, ibtimes.com, minnesota.cbslocal.com

News-Leader.com

September 13
Doctors, Researchers Weigh Pros and Cons of Robotic Surgery – By Sarah Okeson
Article about state-of-the-art robotic surgical system called the da Vinci. Some researchers have questioned whether the outcomes of robotic surgery are any better than conventional surgery and whether using the robotic systems are justified given the increased cost. Danil Makarov, MD, MHS, is quoted.
-Danil V. Makarov, MD, MHS, assistant professor, Department of Urology, assistant professor of Health Policy at The Robert F. Wagner Graduate School of Public Service
Read more: news-leader.com

CancerConnect.com

September
Making Noise Making Progress - By Debra Richardson, MD
Article about ovarian cancer, diagnosed in more than 20,000 women annually in the United States and results in almost 15,000 deaths in this country each year, mentions that NYU Langone Medical Center has a preventive care clinic. The clinic is supported by the Lynne Cohen Foundation for Ovarian Cancer Research (LCFOCR), which is dedicated to supporting groundbreaking research to improve the survival rates of women with ovarian cancer, specifically on the emerging role of screening and prevention.
-NYU Langone Medical Center
Read more: cancerconnect.com

CancerConnect.com

September
Younger by the Hour - By Mia James
Cosmetic surgery to address signs of aging may not be going away anytime soon. In fact, the American Society for Aesthetic Plastic Surgery reported that the demand for plastic surgery rose by almost 9 percent in 2010. Darrell Rigel, MD, is featured.
-Darrell Rigel, MD, clinical professor, Ronald O. Perelman Department of Dermatology
Read more: cancerconnect.com

NY1

Also appeared on International Business Times, Topix.com
September 12
Doctors Find New Generation of Women Gets Hereditary Cancers at Young Age – By Kafi Drexel
Freya Schnabel, MD, appears in segment and comments on a new U.S. study that says women with hereditary cancers are developing them almost eight years earlier than their mothers and grandmothers. The report in the journal Cancer said women are at a greater risk of developing breast or ovarian cancer if they carry the BRCA gene.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: ny1.com

NY1

Also appeared on NY1.com
September 12
IUDs May Reduce Cervical Cancer Risk, Study Finds - By Kafi Drexel
Steven R. Goldstein, MD, is interviewed about intrauterine devices (IUD), a birth control method that may play a significant role in helping women reduce their cervical cancer risk.
-Steven R. Goldstein, MD, professor, Department of Obstetrics and Gynecology
View segment

The Wall Street Journal

Also appeared on The Real Deal
September 8
Cancer Center Nears in N.J. – By Dawn Wotapka
Manhattan-based Tessler Developments says it is near a deal with Jersey City officials to build a proton therapy center on a roughly 2.5-acre parcel. The project comes as another effort to bring proton therapy to the New York City area moves forward with the involvement of some of the area's most prestigious medical centers, including NYU Langone Medical Center.
-NYU Langone Medical Center
Full WSJ article is available at bottom of media report.

Becker’s ASC Review

September 6
Dendritic Cells in Liver Protect Against Acetaminophen Toxicity – By Leigh Page
NYU School of Medicine researchers have discovered that dendritic cells in the liver have a protective role against the toxicity of acetaminophen, the widely used over-the-counter pain reliever and fever reducer for adults and children. The study's findings are published in the September issue of the journal Hepatology.
-NYU School of Medicine
Read more: beckersasc.com

TruthDrive.com

September 3
Dendritic Cells in Liver Protect Against Acetaminophen Toxicity
NYU School of Medicine researchers have discovered that dendritic cells in the liver have a protective role against the toxicity of acetaminophen, the widely used over-the-counter pain reliever and fever reducer for adults and children. The study's findings are published in the September issue of the journal Hepatology. Senior author George Miller, MD, is quoted.
-George Miller, MD, assistant professor, Departments of Surgery and Cell Biology
Read more: truthdive.com

Innovations-Report.com

Also appeared on BioPortfolio.com, News.Cell.com, News-Medical.com, HealthCanal.com, e! Science News, ScienceDaily.com, Bio-Medicine.com, Drug Discovery & Development.com
September 2
Dendritic Cells in Liver Protect Against Acetaminophen Toxicity
NYU School of Medicine researchers have discovered that dendritic cells in the liver have a protective role against the toxicity of acetaminophen, the widely used over-the-counter pain reliever and fever reducer for adults and children. The study's findings are published in the September issue of the journal Hepatology. Senior author George Miller, MD, is quoted.
-George Miller, MD, assistant professor, Departments of Surgery and Cell Biology
Read more: innovations-report.com, bioportfolio.com, news.cell.com, news-medical.net, healthcanal.com, esciencenews.com, sciencedaily.com bio-medicine.org, dddmag.com

August 2011

Einstein.yu.edu

August 30
Dr. Peter B. Schiff: Recalling a Student's Integral Role in Historic Research
Article recaps Peter B. Schiff’s, MD, PhD, medical school experience and his work with Taxol, one of medicine's most widely used anti-tumor drugs.
-Peter B. Schiff, MD, PhD, professor, associate chair for Translational Research, Department of Radiation Oncology
Read more: einstein.yu.edu

WABC-TV

August 25
Cancer Drug Shortages
Dr. James Speyer, medical director of the NYU Clinical Cancer Center discusses the reasons for critical cancer drug shortages in the United States.
- James Speyer, MD, Professor, Department of Medicine and medical director, NYU Clinical Cancer Center
Learn more: abclocal.go.com

Genomeweb.com

August 23
NYU Researchers Win $368K NIH Grant to Study Race and Prostate Cancer - By Justin Petrone
The National Institutes of Health has awarded a $360,000 grant to a team of researchers at NYU School of Medicine and Mount Sinai School of Medicine to study the impact that race has on prostate cancer. Entitled, "Signaling pathway alterations in the racial disparity of prostate cancer," the grant was awarded July 1 and is set to continue until June 2016. Lead investigator Peng Lee, MD, PhD, is quoted.
- Peng Lee, MD, PhD, associate professor, Departments of Urology and Pathology
- NYU School of Medicine
Read more: genomeweb.com (Free login required)

U.S. News & World Report

Also appeared on Drugs.com, DoctorsLounge.com, NewsDay.com, anxietytribe.com
August 22
Trial Drug Shows Preliminary Promise Against Ovarian Cancer - By Robert Preidt, HealthDay
According to a new study, an experimental drug that's shown promise against ovarian cancer caused by mutations in the BRCA1 or BRCA2 genes may also be effective against ovarian cancer not caused by those gene mutations. Stephanie V. Blank, MD, is quoted.
- Stephanie V. Blank, MD, assistant professor, Department of Obstetrics and Gynecology
Read more: healthday.com, health.usnews.com, drugs.com, newsday.com (subscription required)

WIVB.com

Also appeared on WWJ-AM
August 18
Deadliest Skin Cancer Has New Treatment – By Peter Ostrow
Melanoma is the most deadly of all skin cancers. But the FDA has just approved a new medicine that can treat people who have the most advanced forms of the disease. Anna Pavlick, DO, who participated in the new drug’s clinical trials, is quoted along with her patient who was successfully treated with the new drug.
- Anna C. Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and the Department of Medicine, Division of Medical Oncology
Read more: wivb.com, tveyes.com

The Wall Street Journal

Appeared in Wall Street Journal print edition on August 18, FoxNews.com, FierceBiotech.com
August 18
Guided By Genes, Shrinking Cancer - By Jonathan D. Rockoff
A new skin-cancer treatment that promises to shrink tumors and prolong the lives of patients with a particular genetic mutation won speedy approval by the FDA. Vemurafenib, from Roche Holding AG and Daiichi Sankyo Co., belongs to an emerging class of treatments that targets the molecular underpinnings of the cancer. Anna Pavlick, DO, who participated in the new drug’s clinical trials, is quoted along with her patient who was successfully treated with the new drug.
- Anna C. Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and the Department of Medicine, Division of Medical Oncology
Read more: wsj.com, foxnews.com

The Wall Street Journal

CBS Evening News

Also appeared on CBS News.com. Additional coverage also appeared on ABC News.com, ABC News Radio.com, Dow Jones Deutschland
August 17
Melanoma Drug Treatment Approved By FDA – By Dr. Jon Lapook
The FDA recently approved Zelboraf, a drug that can extend survival for the 50% of melanoma patients whose tumors carry the BRAF mutation. Anna Pavlick, DO, who participated in the new drug’s clinical trials, is featured in segment along with her patient.
- Anna C. Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and the Department of Medicine, Division of Medical Oncology
Read more: View CBS Evening News segment, abcnews.go.com kgoam810.com, dowjones.de

WebMD

August 17
Zelboraf Approved for Late-Stage Melanoma - By Daniel J. DeNoon
The FDA recently approved Zelboraf, a drug that can extend survival for the 50% of melanoma patients whose tumors carry the BRAF mutation. Zelboraf is approved for inoperable or late-stage melanoma that tests positive for the BRAF mutation. In concert with the drug approval, the FDA also approved a new test for the BRAF mutation. Anna Pavlick, DO, who participated in the new drug’s clinical trials, is quoted.
- Anna C. Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and the Department of Medicine, Division of Medical Oncology
Read more: webmd.com

U.S. News & World Report

Syndicated HealthDay News story also appeared on Health.com, BioPortfolio.com, HealthLine, HealthFinder.gov, MedBroadcast.com, Bio-Medicine.org, Health.MSN.com, HealthGrades.com
August 17
FDA Approves Novel Melanoma Drug – By Robert Preidt, HealthDay
The U.S. Food and Drug Administration on Wednesday gave its approval to Zelboraf (vemurafenib), a first-of-its-kind drug for the treatment of an often lethal form of melanoma. The drug targets a gene mutation that's present in about half of melanomas, the deadliest form of skin cancer. Anna Pavlick, DO, who participated in the new drug’s clinical trials, is quoted.
- Anna C. Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and the Department of Medicine, Division of Medical Oncology
Read more: healthday.com, health.usnews.com, news.health.com, healthfinder.gov, health.msn.com

CBS Evening News

Also appeared on CBS News.com. Additional coverage also appeared on ABC News.com, ABC News Radio.com, Dow Jones Deutschland
August 17
Melanoma Drug Treatment Approved By FDA – By Dr. Jon Lapook
The FDA recently approved Zelboraf, a drug that can extend survival for the 50% of melanoma patients whose tumors carry the BRAF mutation. Anna Pavlick, DO, who participated in the new drug’s clinical trials, is featured in segment along with her patient.
- Anna C. Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and the Department of Medicine, Division of Medical Oncology
View CBS Evening News segment
Read more: cbsnews.com, abcnews.go.com, dowjones.de

WebMD

U.S. News & World Report

Syndicated HealthDay News story also appeared on Health.com, BioPortfolio.com, HealthLine, HealthFinder.gov, MedBroadcast.com, Bio-Medicine.org, Health.MSN.com, HealthGrades.com
August 17
FDA Approves Novel Melanoma Drug – By Robert Preidt, HealthDay
The U.S. Food and Drug Administration on Wednesday gave its approval to Zelboraf (vemurafenib), a first-of-its-kind drug for the treatment of an often lethal form of melanoma. The drug targets a gene mutation that's present in about half of melanomas, the deadliest form of skin cancer. Anna Pavlick, DO, who participated in the new drug’s clinical trials, is quoted.
- Anna C. Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and the Department of Medicine, Division of Medical Oncology
Read more: healthday.com, health.usnews.com, health.com, bioportfolio.com, xydo.com, healthfinder.gov, medbroadcast.com, bio-medicine.org, health.msn.com, healthgrades.com

The Doctors

August 15
Ask Our Doctors: Skin Care Prevention and Detection
Deborah Sarnoff, MD, answers questions from viewers on how to care for their skin.
- Deborah Sarnoff, MD, clinical professor, Ronald O. Perelman Department of Dermatology
View segment

Bioscience Technology.com

Also appeared on RedOrbit.com, DallasNews.com, Kenya Star, BioPortfolio.com, SciTechReport.com, PharmaLive.com, Bio-Medicine.org, ScienceDaily.com, ScienceNewline.com
August 15
NYU Langone Researchers Identify a Signaling Pathway as Possible Target for Cancer Treatment
In a new study published in the August 16th issue of Developmental Cell, researchers at NYU Langone Medical Center identified a molecular mechanism that guarantees new blood vessels form in the right place and with the proper abundance. Jesús Torres-Vázquez, PhD, is quoted.
- Jesús Torres-Vázquez, PhD, assistant professor, Skirball Institute Program of Developmental Genetics and Cell Biology
Read more: bioprodmag.com, redorbit.com, dallasnews.com, kenyastar.com, bioportfolio.com, scitechreport.com, scitechreport.com, bio-medicine.org, sciencedaily.com

The New York Times

August 15
Cancer’s Secrets Come Into Sharper Focus - By George Johnson
For the last decade cancer research has been guided by a common vision of how a single cell, out-competing its neighbors, evolves into a malignant tumor. Through a series of random mutations, genes that encourage cellular division are pushed into overdrive, while genes that normally send growth-restraining signals are taken offline. Zhiheng Pei, PhD, is quoted.
- Zhiheng Pei, PhD, associate professor, Departments of Pathology and Medicine, Division of Infectious Disease and Immunology
Read more: nytimes.com

MediLexicon.com

Also appeared on Innovations-Report.com
August 12
A Novel Mechanism That Regulates Pro-Inflammatory Cells Is Identified
New research led by Derya Unutmaz, MD, and Mark Sundrud, PhD, of Tempero Pharmaceuticals, Inc., have identified a novel sensory pathway that modulates the potency of Th17 cell responses. The study, highlighted in the August 8th online edition of the Journal of Experimental Medicine, has found that when memory Th17 cells are exposed to a class of secreted proteins called gamma-c cytokines, they become armed to release their potent immune mediators, which are also a family of cytokines.
- Derya Unutmaz, MD, associate professor, Departments of Pathology, Medicine, and Microbiology
Read more: medilexicon.com, innovations-report.com

Innovations-Report.com

Also appeared on FirstScience.com
August 12
A Novel Mechanism That Regulates Pro-Inflammatory Cells Is Identified
New research led by Derya Unutmaz, MD, and Mark Sundrud, PhD, of Tempero Pharmaceuticals, Inc., have identified a novel sensory pathway that modulates the potency of Th17 cell responses. The study, highlighted in the August 8th online edition of the Journal of Experimental Medicine, has found that when memory Th17 cells are exposed to a class of secreted proteins called gamma-c cytokines, they become armed to release their potent immune mediators, which are also a family of cytokines.
- Derya Unutmaz, MD, associate professor, Departments of Pathology, Medicine, and Microbiology
Read more: innovations-report.com, firstscience.com

Reuters

Also appeared on FoxNews.com, WTAQ.com, ChicagoTribune.com
August 4
After Prostate Surgery, Some Men Leak During Sex - By Adam Marcus
Incontinence during sex is a long-lasting problem for roughly one in eight men who've had their prostate removed due to cancer, a study of more than 1,400 patients has found. Herbert Lepor, MD, who led the new study that looked at responses to questionnaires from 1,459 men who had undergone radical prostatectomy at NYU's Langone Medical Center between 2000 and 2007, is quoted.
- Herbert Lepor, MD, professor and Martin Spatz Chair, Department of Urology
Read more: reuters.com, news.yahoo.com, foxnews.com, wtaq.com, chicagotribune.com

ModernMedicine.com

August 1
Melanoma Data Underscore Magnitude of Tanning Behaviors - By Diane Donofrio Angelucci
Darrell S. Rigel, MD, is featured in article about melanoma and says it is increasing faster than any other type of cancer in the United States, and a large portion of this increase is among young women.
- Darrell Rigel, MD, clinical professor, Ronald O. Perelman Department of Dermatology
Read more: modernmedicine.com

July 2011

Cosmopolitan

July 2011 Issue
Cosmo's 2011 Practice Safe Sun Awards
Jennifer A. Stein, MD, is featured. Article quotes Dr. Stein who says her "goal is to inform women how tanning will impact their health."
- Jennifer Stein, MD, PhD, assistant professor, Ronald O. Perelman Department of Dermatology

NY 1 Noticias

July 20
Breast Cancer Screening Guidelines Issued - Jonathan Inoa
The American College of Obstetricians and Gynecologists issued new breast cancer screening guidelines on July 20. They recommend women receive mammogram screenings beginning at age 40. Dr. Cristina Checka and her patient were interviewed.
- Cristina Checka, MD, assistant professor, Department of Surgery
Watch more: http://www.ny1noticias.com/content/principales/salud/143334/estudio-reco... (In Spanish)

National Institute of General Medical Sciences

July 20
NYU Researchers Develop Compound to Block Signaling Of Cancer-Causing Protein
Researchers at New York University's Department of Chemistry and NYU Langone Medical Center have developed a compound that blocks signaling from a protein implicated in many types of cancer.
- Dafna Bar-Sagi, PhD, chair and professor, Department of Biochemistry
- Kamlesh Yadav, graduate student in the Department of Biochemistry
- Paramjit Arora, PhD, associate professor, Department of Chemistry
- Anupam Patgiri, graduate student in the Department of Chemistry
Read More: http://www.nigms.nih.gov/

US News & World Report

July 19
NYU Langone Medical Center Nationally Ranked In U.S. News "2011-2012 Best Hospitals"
NYU Langone Medical Center is ranked amongst the nation's best in 15 specialty areas in the 2011-2012 U.S. News & World Report's annual survey of "Best Hospitals" in America. The specialty areas are: Cancer, Cardiology & Heart Surgery, Gastroenterology, Geriatrics, Gynecology, Diabetes & Endocrinology, Ear, Nose and Throat, Nephrology, Neurology & Neurosurgery, Orthopaedics, Psychiatry, Pulmonology, Rehabilitation, Rheumatology and Urology. The Medical Center's rehabilitation, rheumatology, and orthopaedics programs were all recognized in the top 10 nationwide, marking the 22nd consecutive year that rehabilitation held this honor as well as being the #1 rehabilitation program in New York State. The Medical Center is also ranked the #2 hospital in the New York metro area based on the number of nationally recognized specialty areas.
- NYU Langone Medical Center
Learn more: http://health.usnews.com/best-hospitals/nyu-langone-medical-center-6212925
NYU Langone's Press Release: http://communications.med.nyu.edu/media-relations/news/nyu-langone-medic...

TRIBLocal

July 18
Hair Turning Gray is Just a Protein Problem - By Chris Hammerlund
Researchers at NYU Langone Medical Center in New York, report when the signaling pathway is activated by the protein, the melanocytes produce pigments that color hair. The study shows that when they are turned off because the protein doesn't work, the melanocytes don't produce color, and that makes your hair gray.
- Mayumi Ito, PhD, assistant professor, Departments of Cell Biology and Ronald O. Perelman Department of Dermatology
Learn more: http://triblocal.com/gurnee/community/stories/2011/07/hair-turning-gray-...

BioScholar News

July 18
Compound to Block Signaling of Cancer-causing Protein Developed
Researchers at NYU's Department of Chemistry and NYU Langone Medical Center examined signaling by receptor tyrosine kinase (RTK). The researchers note that synthetic Sos may offer a lead for the creation of pharmaceuticals that can block Sos-Ras interaction. The compound is described in the latest issue of the journal Nature Chemical Biology.
- Dafna Bar-Sagi, PhD, chair and professor, Department of Biochemistry
- Kamlesh Yadav, graduate student in the Department of Biochemistry
- Paramjit Arora, associate professor, Department of Chemistry
- Anupam Patgiri, graduate student in the Department of Chemistry
Learn more: http://news.bioscholar.com/2011/07/compound-to-block-signalling-of-cance...
http://www.biosciencetechnology.com/News/2011/07/NYU-researchers-develop...
http://www.news-medical.net/news/20110718/Novel-compound-blocks-signalin...
http://www.redorbit.com/news/health/2080774/nyu_researchers_develop_comp...

Asian News International

July 18
Compound To Block Signaling Of Cancer-Causing Protein Developed - By News Desk
Scientists have developed a compound that blocks signaling from a protein implicated in many types of cancer. Researchers at New York University's Department of Chemistry and NYU Langone Medical Center examined signaling by receptor tyrosine kinase (RTK).
- NYU Langone Medical Center
Learn more: http://truthdive.com/2011/07/18/Compound-to-block-signalling-of-cancer-c...
http://www.eurasiareview.com/compound-to-block-signaling-of-cancer-causi...
http://www.laboratoryequipment.com/news-A-Complex-to-Block-Cancer-Causin...

EScienceNews

July 17
NYU Researchers Develop Compound to Block Signaling Of Cancer-Causing Protein
Researchers at New York University's Department of Chemistry and NYU Langone Medical Center have developed a compound that blocks signaling from a protein implicated in many types of cancer.
- Dafna Bar-Sagi, chair and professor, Department of Biochemistry
- Kamlesh Yadav, graduate student in the Department of Biochemistry
- Paramjit Arora, associate professor, Department of Chemistry
- Anupam Patgiri, graduate student in the Department of Chemistry
Learn more: http://esciencenews.com/sources/science.daily/2011/07/17/compound.block....
http://www.chemspy.com/nyu-researchers-develop-compound-to-block-signali...
http://www.rxpgnews.com/cancer-research/NYU-researchers-develop-compound...
http://www.rdmag.com/News/Feeds/2011/07/materials-nyu-researchers-develo...
http://www.sciencedaily.com/releases/2011/07/110717134811.htm
http://anpron.eu/?p=14801
http://www.sciencenewsline.com/medicine/2011071801450005.html
http://www.firstscience.com/home/news/breaking-news-all-topics/nyu-resea...
http://rockhall.msg.com/article/06xXazefx9gki?q=National+Institutes+of+H...
http://feedmyscience.com/news/NYU+researchers+develop+compound+to+block+...
http://discoverybuzz.com/story/NYU-researchers-develop-compou-50970/
http://www.google.com/search?q=NYU+researchers+develop+compound+to+block...
http://digg.com/news/science/researchers_develop_compound_to_block_signa...
http://onespot.wsj.com/taxes/2011/07/18/90439/researchers-develop-compou...
http://cb.openmolecules.net/
http://compounds.asia/news
http://wotnews.com.au/like/nyu_researchers_develop_compound_to_block_sig...
http://www.physorg.com/technology-news/computer-sciences/
http://www.rxpgnews.com/cancer-research/NYU-researchers-develop-compound...
http://www.newspond.com/story=3906620
http://rxjournals.com/researchers-develop-compound-to-block-signaling-of...
http://rxjournals.com/researchers-develop-compound-to-block-signaling-of...
http://medicalxpress.com/news/2011-07-compound-block-cancer-causing-prot...

Yahoo! Finance

Also appeared on BioPortfolio.com, MorningStar.com, SYS-CON.com, SFGate.com, Ulitzer.com
July 14
Rosetta Genomics Launches miRview(R) Lung Test
Rosetta Genomics, a developer and provider of microRNA-based molecular diagnostic tests, announced the launch of miRview® lung, an advanced microRNA test that differentiates neuroendocrine tumors from non-small cell lung tumors (NSCLC). Harvey Pass, MD, comments on the clinical importance of the assay.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
Read more: http://finance.yahoo.com/news/Rosetta-Genomics-Launches-iw-1875870547.ht...
http://www.bioportfolio.com/news/article/741525/Rosetta-Genomics-Launche...
http://news.morningstar.com/all/market-wire/11777771/rosetta-genomics-la...
http://www.sys-con.com/node/1908564
http://finance.sfgate.com/hearst.sfgate/news/read?GUID=18963373
http://www.ulitzer.com/node/1908564

MedIndia.com

July 13
Key Role of MicroRNAs In Melanoma Metastasis Identified
Researchers at the NYU Cancer Institute identified for the first time the key role specific microRNAs (miRNAs) play in melanoma metastasis to simultaneously cause cancer cells to invade and immunosuppress the human body's ability to fight abnormal cells. The new study is published in the July 11, 2011 issue of the journal Cancer Cell. Authors Eva Hernando, PhD, is quoted.
- Eva Hernando, PhD, assistant professor, Department of Pathology
Read more: http://www.medindia.net/news/Key-Role-Of-MicroRNAs-In-Melanoma-Metastasi...

ScienceDaily.com

Also appeared on e! Science News.com, DayLife.com, BioPortfolio.com, MediLexicon.com, MedicalNewsToday.com, Bio-Medicine.org, MedicalXpress.com, BioscienceTechnology.com
July 12
Researchers Identify Key Role of MicroRNAs in Melanoma Metastasis
Researchers at the NYU Cancer Institute identified for the first time the key role specific microRNAs (miRNAs) play in melanoma metastasis to simultaneously cause cancer cells to invade and immunosuppress the human body's ability to fight abnormal cells. The new study is published in the July 11, 2011 issue of the journal Cancer Cell. Authors Eva Hernando, PhD, and Avital Gaziel-Sovran, graduate assistant, are quoted.
- Eva Hernando, PhD, assistant professor, Department of Pathology
- Avital Gaziel-Sovran, graduate assistant, Department of Pathology
Read more: http://www.sciencedaily.com/releases/2011/07/110711164541.htm
http://www.medilexicon.com/medicalnews.php?newsid=230853
http://esciencenews.com/articles/2011/07/11/researchers.identify.key.rol...
http://www.daylife.com/article/08vv4Mk32U5Af?q=Cancer
http://www.bioportfolio.com/news/article/738052/Researchers-Identify-Key...
http://www.medicalnewstoday.com/releases/230853.php
http://www.bio-medicine.org/medicine-news-1/Researchers-identify-key-rol...
http://medicalxpress.com/news/2011-07-key-role-micrornas-melanoma-metast...
http://www.biosciencetechnology.com/News/2011/07/Researchers-identify-ke...

Yahoo! Shine

July 12
Are You Putting Blind Faith in Your Sunscreen? 5 Scary SPF secrets
Sunscreen is the best way to ward off damaging rays, but the Environmental Working Group reviewed nearly 1,400 sunscreens in 2010 and found only 8 percent made the grade in terms of preventing skin cancer and signs of aging. Article provides facts and tips to keep skin healthy. Robert J. Friedman, MD, is quoted.
- Robert J. Friedman, MD, clinical professor, Ronald O. Perelman Department of Dermatology
Read more: http://shine.yahoo.com/channel/health/are-you-putting-blind-faith-in-you...

MedicalPhysicsWeb.org

Also appeared on Asian Hospital & Healthcare Management.com
July 8
Significant Rise in Survival Rates for Elderly Lung Cancer Patients Treated Using Radiosurgery in Netherlands Detailed at World Conference for Lung Cancer
Harvey Pass, MD, presented state-of-the-art approaches to tackling early-stage lung cancer at the World Conference on Lung Cancer's symposium entitled "Expanding Options for High-Risk Operable Non Small-Cell Lung Cancer (NSCLC) Patients." Dr. Pass also outlined the latest results of a small phase-2 study he is leading to investigate what is suitable for operable patients.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
Read more: http://medicalphysicsweb.org/cws/article/newsfeed/46477
http://www.asianhhm.com/news/news_archives.asp?NewsID=621

MedicalXPress.com

July 1
Gene Mutation Contributes to Leukemia by Enhancing Function of Blood Stem Cells
Iannis Aifantis, PhD, and colleagues discovered a mutation in TET2 enhances the function of blood stem cells in the bone marrow, causing them to renew themselves more efficiently than normal blood stem cells and results in a greater number of mutant cells than normal blood stem cells, a condition that leads to leukemia. The study was published in the July issue of Cancer Cell.
- Iannis Aifantis, PhD, associate professor, Department of Pathology
Read more: http://medicalxpress.com/news/2011-07-gene-mutation-contributes-leukemia...

NBC.com Syndicates

Also appeared on ABC Syndicates, Fox Syndicates, CBS Syndicates, Rehab Management, PharmacyChoice.com, Benzinga.com, MorningStar.com, ABBANetwork.com, DeviceSpace.com
July 6
Significant Rise in Survival Rates for Elderly Lung Cancer Patients Treated Using Radiosurgery in Netherlands Detailed at World Conference for Lung Cancer
Harvey Pass, MD, presented state-of-the-art approaches to tackling early-stage lung cancer at the World Conference on Lung Cancer's symposium entitled "Expanding Options for High-Risk Operable Non Small-Cell Lung Cancer (NSCLC) Patients." Dr. Pass also outlined the latest results of a small phase-2 study he is leading to investigate what is suitable for operable patients.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
Read more: http://www.wvva.com/story/15032579/significant-rise-in-survival-rates-fo...
http://www.wxow.com/story/15032579/significant-rise-in-survival-rates-fo...
http://www.kptm.com/story/15032579/significant-rise-in-survival-rates-fo...
http://www.woio.com/story/15032579/significant-rise-in-survival-rates-fo...
http://www.rehabpub.com/press_release.asp?id=10253581
http://www.pharmacychoice.com/News/article.cfm?Article_ID=747113
http://www.benzinga.com/pressreleases/11/07/n1740296/significant-rise-in...
http://news.morningstar.com/all/pr-news-wire/20110706SF30710/significant...
http://www.abbanetwork.com/health/significant-rise-in-survival-rates-for...
http://www.devicespace.com/news_story.aspx?NewsEntityId=226079

RedOrbit.com

Also appeared on SYS-CON Media.com
July 6
Significant Rise in Survival Rates for Elderly Lung Cancer Patients Treated Using Radiosurgery in Netherlands Detailed at World Conference for Lung Cancer
Harvey Pass, MD, presented state-of-the-art approaches to tackling early-stage lung cancer, detailing results of local tumor control after two and three years in non-operable patients at the World Conference on Lung Cancer's symposium entitled "Expanding Options for High-Risk Operable Non Small-Cell Lung Cancer (NSCLC) Patients." Dr. Pass also outlined the latest results of a small phase-2 study he is leading to investigate whether SBRT is suitable for operable patients.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
Read more: http://www.redorbit.com/news/health/2074710/significant_rise_in_survival...
http://www.sys-con.com/node/1898526

ABC News.com

Also appeared on 670KBOI.com, WGOWAM.com, 100WAPI.com, WBSM.com, CafeMom.com
July 6
Researchers Seek to Explain Sunburn Pain
British researchers have discovered a molecule responsible for the persistent pain caused by sunburn, offering hope for a treatment that could one day block it. Darrell Rigel, MD, comments on what individuals can do to protect themselves from the sun and how to treat sunburn pain.
- Darrell Rigel, MD, clinical professor, Ronald O. Perelman Department of Dermatology
Read more: http://abcnews.go.com/Health/Wellness/sunburn-pain-explained-tips-beat/s...
http://www.670kboi.com/rssItem.asp?feedid=116&itemid=29689502
http://www.wgowam.com/rssItem.asp?feedid=116&itemid=29689502
http://www.100wapi.com/rssItem.asp?feedid=116&itemid=29689502
http://www.wbsm.com/rssItem.asp?feedid=116&itemid=29689502
http://www.cafemom.com/group/110860/forums/read/14442878/How_to_beat_sun...

Cosmopolitan

July 2011 Issue
The Scary New Oral-Sex Risk – By Holly Pevzner
Scientists have found a link between hooking up and cancer, and doctors are seeing a rise in young women being diagnosed. Mark D. DeLacure, MD, says HPV, that causes cervical cancer, can be spread through direct skin contact during intercourse, as well as during oral sex.
- Mark D. DeLacure, MD, associate professor, Departments of Otolaryngology, Surgery, and Plastic Surgery, Division of Head and Neck Surgery and Oncology

OBG Management

July 2011
"Does Cancer Cause Menorrhagia?"A Lament on the Decline of the Art of Medicine - By Steven R. Goldstein, MD
Steven R. Goldstein, MD, says contemporary medical training teaches residents how to regurgitate information on demand, but it doesn't do so well at showing them how to apply knowledge to common scenarios.
- Steven R. Goldstein, MD, professor, Department of Obstetrics and Gynecology
Read more: obgmanagement.com

June 2011

HealthCanal.com

June 30
Gene Mutation Contributes to Leukemia by Enhancing Function of Blood Stem Cells
Iannis Aifantis, PhD, and colleagues discovered a mutation in TET2 enhances the function of blood stem cells in the bone marrow, causing them to renew themselves more efficiently than normal blood stem cells and results in a greater number of mutant cells than normal blood stem cells, a condition that leads to leukemia. The study was published in the July issue of Cancer Cell.
-Iannis Aifantis, PhD, associate professor, Department of Pathology
Read more: http://www.healthcanal.com/cancers/18546-Gene-Mutation-Contributes-Leuke...

Metro

June 28
Protecting Your Skin from Sun Damage – By Tina Chadha
Kenneth Mark, MD, is featured and explains new FDA regulations for sunscreen and what individuals need to know when spending time in the sun.
-Kenneth Mark, MD, clinical assistant professor, Ronald O. Perelman Department of Dermatology
Read more: http://www.metro.us/newyork/life/article/903052--protecting-your-skin-fr...

BioTechDaily.com

June 28
New Clues May Explain Why Hair Turns Gray
According to a new study by researchers at NYU Langone, communication between hair follicles and melanocyte stem cells, mediated by Wnt signaling (already known to control many biological processes) can dictate hair pigmentation. Lead author Mayumi Ito, PhD, is quoted.
-Mayumi Ito, PhD, assistant professor, Department of Cell Biology and the Ronald O. Perelman Department of Dermatology
Read more: http://www.biotechdaily.com/?option=com_article&Itemid=294735779&printve...

Men's Health.com

June 24
Go Gray—the Right Way – By Andrew Katz
For the first time, researchers at NYU Langone have identified the root cause of how hair color fades. Researchers examined a protein called “wnt” that activates color-supplying stem cells to produce pigment. According to lead researcher Mayumi Ito, PhD, when the protein is inhibited, hair re-growth slows, and those stem cells lose their ability to produce color—resulting in gray hair.
-Mayumi Ito, PhD, assistant professor, Department of Cell Biology and the Ronald O. Perelman Department of Dermatology
Read more: http://blogs.menshealth.com/health-headlines/go-gray%E2%80%94the-right-w...

NY Daily News

June 23
Prostate Exam Easier If Friends Come Along; Daily News Offering Free PSA Testing – By Lillian Rizzo
Dean Cisluycis, an engineer at the city medical examiner's office, sat with three co-workers at NYU Langone this week waiting to take free PSA exams sponsored by the Daily News.
-NYU Langone Medical Center
Read more: http://www.nydailynews.com/lifestyle/health/2011/06/23/2011-06-23_friend...

ABCNews.com

Also appeared on MedpageToday.com
June 23
Chemo Drug Taxol Shortage Puts Cancer Patients at Risk
Article about the shortage of the chemotherapy drug Taxol quotes James Speyer, MD.
-James L. Speyer, MD, professor, NYU Department of Medicine
Read more:
http://abcnews.go.com/Health/CancerPreventionAndTreatment/chemo-drug-tax...
http://www.medpagetoday.com/HematologyOncology/Chemotherapy/27249

Today's Health.com

June 21
Is Your Thyroid on the Fritz? - By Hallie Levine Sklar, Women's Health
Article about thyroid disorders and their effects quotes Keith Heller, MD.
-Keith S. Heller, MD, professor, Department of Surgery, chief, Division of Endocrine Surgery
Read more: http://today.msnbc.msn.com/id/43492653/ns/today-today_health/

MSNBC.com

Also appeared on BioNews.org.uk
June 20
Science of the Silver Fox: Why Hair Goes Gray – By Cari Nierenberg
A new study by researchers at NYU Langone has shown Wnt signaling, already known to control many biological processes, between hair follicles and melanocyte stem cells can dictate hair pigmentation. Mayumi Ito, PhD, is quoted.
-Mayumi Ito, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
Read more:
http://bodyodd.msnbc.msn.com/_news/2011/06/20/6902591-science-of-the-sil...
http://www.bionews.org.uk/page_97325.asp

GenomeWeb.com

June 16
NYU/Exiqon Team Finds New Blood-Based miRNA Markers for Melanoma Recurrence - By Molika Ashford
Researchers from NYU Langone, working with diagnostic company Exiqon, have identified several blood-based microRNAs with the potential to be used as biomarkers for melanoma recurrence risk. Results were presented at the annual meeting of the American Society of Clinical Oncology earlier this month.
-NYU Langone Medical Center
Read more:
http://www.genomeweb.com/rnai/nyuexiqon-team-finds-new-blood-based-mirna...

MedicineNet.com

Also appeared on MedBroadcast.com
June 16
FDA Approves Test That Spots Aggressive Breast Cancer - By Robert Preidt
A new genetic test that helps determine if breast cancer patients are good candidates for treatment with the drug Herceptin was approved Tuesday by the U.S. Food and Drug Administration. Freya Schnabel, MD, is quoted.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more:
http://www.medicinenet.com/script/main/art.asp?articlekey=145766
http://www.medbroadcast.com/channel_health_news_details.asp?news_channel...

HealthDay

Also appeared on YAHOO! News, YAHOO! News India, TheWallStreetJournal.com, HealthGrades.com, MSN.com, iVillage.com, WomensHealth.gov, BioMedicine.com, HealthFinder.gov
Additional stories include U.S. News & World Report, DiscoverNews.com, AllVoices.com, DNAIndia.com, Examiner.com, LiveScience.com, YAHOO! News, Cosmetics & Toiletries
June 16
Mouse Study Uncovers the Roots of Gray Hair – By Mary Elizabeth Dallas
A new study suggests the roots of gray hair may lie in a particular type of communication between hair follicles and melanocyte stem cells, the cells that make and store the pigments in skin and hair, a new study suggests. Mayumi Ito, PhD, is quoted.
-Mayumi Ito, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
Read more:
http://consumer.healthday.com/Article.asp?AID=653946
http://news.yahoo.com/s/hsn/20110616/hl_hsn/mousestudyuncoverstherootsof...
http://in.news.yahoo.com/mouse-study-uncovers-roots-gray-hair-210505532....
http://onespot.wsj.com/health/2011/06/16/3b1b2/mouse-study-uncovers-the-...
http://www.healthgrades.com/health-news/ArticleDetail.aspx?id=653946
http://health.msn.com/health-topics/aging/articlepage.aspx?cp-documentid...
http://www.ivillage.com/mouse-study-uncovers-roots-gray-hair/4-a-358641
http://womenshealth.gov/news/english/653946.htm
http://www.bio-medicine.org/medicine-news-1/Mouse-Study-Uncovers-the-Roo...
http://www.healthfinder.gov/news/newsstory.aspx?docID=653946
http://www.usnews.com/science/articles/2011/06/16/new-research-provides-...
http://news.discovery.com/human/how-hair-turns-gray-110617.html
http://www.allvoices.com//contributed-news/9417222-research-finds-protei...
http://www.dnaindia.com/scitech/report_why-our-hair-turns-grey_1555281
http://www.examiner.com/natural-health-in-atlanta/research-finds-protein...
http://www.livescience.com/14643-scientists-uncover-secrets-hair-turns-g...

YAHOO! News Singapore

Also appeared on News-Medical.net, Sify News.com, ScienceDaily.com, e! Science News, MedicalXpress.com, Bio-Medicine.org, LabSpaces.net, FindBiometrics.com, TruthDrive.com, Newsroom America.com, Reuptake.org, TimesofIndia.com, RedOrbit.com
June 15
Wnt Signaling May Help Target Hair Pigmentation
A new study by researchers at NYU Langone has shown Wnt signaling, already known to control many biological processes, between hair follicles and melanocyte stem cells can dictate hair pigmentation. The study was published in the June 11, 2011 issue of the journal Cell.
-Mayumi Ito, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
Read more:
http://sg.news.yahoo.com/why-hair-turns-grey-065325534.html
http://www.news-medical.net/news/20110615/Wnt-signaling-may-help-target-...
http://www.sify.com/news/why-our-hair-turns-grey-news-international-lgpm...
http://www.sciencedaily.com/releases/2011/06/110614115046.htm
http://esciencenews.com/articles/2011/06/14/new.research.provides.clues....
http://medicalxpress.com/news/2011-06-clues-hair-gray.html
http://www.bio-medicine.org/biology-news-1/New-research-provides-clues-o...
http://www.labspaces.net/111355/New_research_provides_clues_on_why_hair_...
http://www.findbiometrics.com/industry-news/i/9032/
http://truthdive.com/2011/06/15/Why-our-hair-turns-grey.html
http://www.newsroomamerica.com/story/139339/new_research_provides_clues_...
http://reuptake.org/2011/06/14/wnt-signaling-and-hair-color/
http://timesofindia.indiatimes.com/life-style/health-fitness/health/Why-...
http://www.redorbit.com/news/health/2064597/why_does_our_hair_turn_gray/

Woman's Day

June 15
New Sunscreen Rules - By Barbara Brody
The FDA announced yesterday new sunscreen regulations that will take effect next year. Article lists the main changes in labeling you should know about. Jennifer A. Stein, MD, PhD, is quoted.
-Jennifer A. Stein, MD, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
Read more: http://dailywd.womansday.com/health/daily-dose/2011/sunscreen-rules/

LiveScience.com

Also appeared on YAHOO! News Singapore, MyHealthNewsDaily.com
June 15
How to Choose the Best Sunscreen: What New FDA Rules Mean - By Rachael Rettner
According to the new Food and Drug Administration (FDA) rules announced yesterday that will take effect in 2012, sunscreen makers will no longer be able use alluring labels without meeting certain requirements. Ariel Ostad, MD, is quoted. Article describes what individuals should look for when purchasing sunscreen.
-Ariel Ostad, MD, clinical assistant professor, Ronald O. Perelman Department of Dermatology
Read more:
http://www.livescience.com/14622-choose-sunscreen-fda-rules.html
http://sg.news.yahoo.com/choose-best-sunscreen-fda-rules-mean-225404910....
http://www.myhealthnewsdaily.com/sunscreen-label-fda-rules-broad-spectru...

iVillage.com

Also appeared on EveryDayHealth.com
June 15
FDA Issues New Rules on Sunscreens - By Steven Reinberg
The U.S. Food and Drug Administration said Tuesday it will require new labeling for sunscreens to identify products that are best for reducing the risk of skin cancer, early skin aging, and helping to prevent sunburn. Jennifer A. Stein, MD, PhD, is quoted.
-Jennifer A. Stein, MD, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
Read more:
http://www.ivillage.com/fda-issues-new-rules-sunscreens/4-a-357809
http://www.everydayhealth.com/skin-and-beauty/0614/fda-issues-new-rules-...

HealthFinder.gov

Also appeared on SecondAct.com
June 14
FDA Issues New Rules on Sunscreens - By Steven Reinberg
The U.S. Food and Drug Administration said Tuesday it will require new labeling for sunscreens to identify products that are best for reducing the risk of skin cancer, early skin aging, and helping to prevent sunburn. Jennifer A. Stein, MD, PhD, is quoted.
-Jennifer A. Stein, MD, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
Read more:
http://www.healthfinder.gov/news/newsstory.aspx?docID=653913
http://www.secondact.com/2011/06/fda-issues-new-rules-on-sunscreens/

ABC World News Tonight

June 14
Sunscreen to Have Stricter Labeling to Protect Against Cancer-Causing UVA Light - By Lara Salahi
New sunscreen labels will include a marking to show for the first time how well the product protects users against cancer-causing ultraviolet A (UVA) light. Darell Rigel, MD, is quoted.
-Darrell Rigel, MD, clinical professor, Ronald O. Perelman Department of Dermatology
Read more: http://abcnews.go.com/Health/SkinCare/sunscreen-stricter-labeling-protec...

HealthDay

Also appeared on U.S. News & World Report, YAHOO! News, Health.com
June 14
FDA Issues New Rules on Sunscreens - By Steven Reinberg
The U.S. Food and Drug Administration said Tuesday it will require new labeling for sunscreens to identify products that are best for reducing the risk of skin cancer, early skin aging and helping to prevent sunburn. Jennifer A. Stein, MD, is quoted.
-Jennifer A. Stein, MD, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
Read more:
http://consumer.healthday.com/Article.asp?AID=653913
http://health.usnews.com/health-news/family-health/cancer/articles/2011/...
http://news.yahoo.com/s/hsn/20110614/hl_hsn/fdaissuesnewrulesonsunscreens
http://news.health.com/2011/06/14/fda-issues-new-rules-on-sunscreens/

HealthDay

Also appeared on YAHOO! News, YAHOO! News India, U.S. News & World Report Health, Health.com, BioPortfolio.com, DayLife.com
June 14
FDA Approves Test That Spots Aggressive Breast Cancer - By Robert Preidt
A new genetic test that helps determine if breast cancer patients are good candidates for treatment with the drug Herceptin was approved Tuesday by the U.S. Food and Drug Administration. Freya Schnabel, MD, is quoted.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more:
http://consumer.healthday.com/Article.asp?AID=653918
http://in.news.yahoo.com/fda-approves-test-spots-aggressive-breast-cance...
http://health.usnews.com/health-news/family-health/cancer/articles/2011/...
http://news.health.com/2011/06/14/fda-approves-test-that-spots-aggressiv...
http://www.bioportfolio.com/news/article/711313/Fda-Approves-Test-That-S...
http://www.daylife.com/article/0gXMftV7w97oJ?q=Tucson

New York Magazine Best Doctors

June 13 Issue
In the O.R. for Life-Changing Surgery--Amputating a Leg
Timothy B. Rapp, MD, is profiled in NY Magazine’s 14th annual Best Doctors issue. Article highlights the amputation of a patient’s lower leg by Dr. Rapp, who has a soft-tissue sarcoma, a cancer that can occur in connective tissue like bone and cartilage.
-Timothy B. Rapp, MD, associate professor, Department of Orthopaedic Surgery
Read more:
http://nymag.com/health/bestdoctors/2011/amputation/
http://nymag.com/bestdoctors/

The Baltimore Sun

June 13
On 'Men of a Certain Age,' Questions Arise About Colon Cancer and Chemo - By Marc K. Siegel, MD
In light of a recent "Men of a Certain Age" episode, Marc Siegel, MD, provides insight into the realities of colon cancer screenings, prognosis, treatment options, and emotional support.
-Marc K. Siegel, MD, clinical associate professor, Department of Medicine, Division of General Internal Medicine
Read more: http://www.baltimoresun.com/health/la-he-unreal-men-of-a-certain-age-201...

ASCO Daily News

June 8
Biomarkers in Lung Cancer
Harvey I. Pass, MD, discussed the EDRN effort and provided an update on the use of biomarkers in the treatment of lung cancer at the ASCO 2011 annual meeting.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
Read more: http://chicago2011.asco.org/ASCODailyNews/Biomarkers.aspx

ABC News.com

June 8
Birth Control Pill for Men: Would You Count On It? - By Katie Moisse
Scientists could be one step closer to developing a birth control pill for men. A drug that stunts sperm production in mouse testes, and if it's proven to be safe and effective in humans, it could expand the prophylactic pool. Joseph Alukal, MD, is quoted.
-Joseph P. Alukal, MD, assistant professor, Department of Urology
Read more: http://abcnews.go.com/Health/WomensHealth/birth-control-pill-men-count/s...

CBS 2 News

June 8
Skin Safety - By Cindy Hsu
Jennifer Stein, MD, PhD, is featured in segment about skin safety. Dr. Stein says it's not too late to change habits to protect your skin.
- Jennifer Stein, MD, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
View segment

Oral Cancer & Diagnostics

June 8
What Causes Diagnostic Delays in Head/Neck Cancer?
Patients' lack of English literacy and their employment status do not contribute to delays in head and neck cancer diagnoses -- in fact, quite the opposite, according to a presentation by researchers at NYU Langone Medical Center at the American Society of Clinical Oncology annual meeting this week in Chicago.
-NYU Langone Medical Center
Read more: http://www.drbicuspid.com/index.aspx?Sec=sup&Sub=orc&pag=dis&ItemID=3078...

ABC News Radio

June 8
Birth Control Pill for Men: Would You Count On It?
Scientists could be one step closer to developing a birth control pill for men. A drug that stunts sperm production in mouse testes, and if it's proven to be safe and effective in humans, it could expand the prophylactic pool. Joseph Alukal, MD, is quoted.
-Joseph P. Alukal, MD, assistant professor, Department of Urology
Read more: http://wlsam.com/Article.asp?id=2207710&spid=

Medical News Today

Also appeared on News-Medical.net, ScienceNewsline.com, The Breast Cancer Network News
June 7
Experts From The NYU Cancer Institute Present At ASCO 2011 Annual Meeting
Experts from the NYU Cancer Institute presented new research findings at the 47th American Society of Clinical Oncology (ASCO) 2011 Annual Meeting that took place June 3-7, 2011. Scientists presented various new research findings in melanoma, breast cancer, head & neck cancer, prostate cancer and pediatric oncology.
-NYU Cancer Institute
Read more:
http://www.medicalnewstoday.com/releases/227677.php
http://www.news-medical.net/news/20110608/NYU-Cancer-Institute-scientist...
http://www.sciencenewsline.com/medicine/2011060708020057.html
http://www.thebcnnews.com/1.php

DeviceSpace

June 7
Exiqon Together With NYU Cancer Institute Announces Presentation of Results at the 2011 ASCO Annual Meeting
NYU Cancer Institute Interdisciplinary Melanoma Program (IMCG) together with Exiqon, announces results at the 2011 ASCO Annual meeting showing the use of microRNAs as biomarkers in melanoma.
-NYU Cancer Institute
Read more: http://www.devicespace.com/news_story.aspx?StoryID=223259&full=1

All Voices

June 6
Treatment Breakthroughs for Skin Cancer Patients – By J.R. Huetteman
Researchers reported Sunday on the clinical trials of two new drugs that can greatly increase the survival rate in patients that suffer from metatstatic melanoma. Sylvia Adams, MD, is quoted.
-Sylvia Adams, MD, assistant professor, Department of Medicine, Division of Oncology
Read more: http://www.allvoices.com/contributed-news/9313814-treatment-breakthrough...

REUTERS

Also appeared on EuroInvestor.co.uk, TechNews.TMCnet.com, IndiaTimes.com
June 6
Exiqon Together With NYU Cancer Institute Announces Presentation of Results at the 2011 ASCO Annual Meeting
NYU Cancer Institute Interdisciplinary Melanoma Program (IMCG) together with Exiqon, announces results at the 2011 ASCO Annual meeting showing the use of microRNAs as biomarkers in melanoma.
-NYU Cancer Institute
Read more:
http://www.reuters.com/article/2011/06/06/idUS143123+06-Jun-2011+GNW2011...
http://www.euroinvestor.co.uk/news/story.aspx?id=11720251
http://technews.tmcnet.com/news/2011/06/06/5555538.htm
http://1click.indiatimes.com/article/090e2qKg3r8Sq?q=Copenhagen

The Los Angeles Times

June 6
Drugs Hailed as a 'Major Breakthrough' in Treating Deadly Skin Cancer - By Thomas H. Maugh II
Researchers report two new drugs can significantly increase survival in patients with metastatic melanoma, the advanced and generally lethal form of skin cancer. Sylvia Adams, MD, is quoted.
-Sylvia Adams, MD, assistant professor, Department of Medicine, Division of Oncology
Read more: http://www.latimes.com/health/la-he-melanoma-drugs-20110606,0,1330185.story

Barron’s

Also appeared on Stockhouse.com, Cisionwire.com
June 6
Exiqon Together With NYU Cancer Institute Announces Presentation of Results at the 2011 ASCO Annual Meeting
NYU Cancer Institute Interdisciplinary Melanoma Program (IMCG) together with Exiqon, announces results at the 2011 ASCO Annual meeting showing the use of microRNAs as biomarkers in melanoma.
-NYU Cancer Institute
Read more:
http://online.barrons.com/article/PR-CO-20110606-906670.html
http://www.stockhouse.com/News/USReleasesDetail.aspx?n=8196289
http://www.cisionwire.com/exiqon-a-s-g/r/exiqon-together-with-nyu-cancer...

CBS Newspath

Also appeared on CBS 4 WTVY.com
June 6
New Drug May Prevent Breast Cancer - By Eric Roby and Suzanne Boyd
A new study of high risk women finds a drug already approved to treat breast cancer may prevent it. Freya Schnabel, MD, is quoted.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: http://www.wtvy.com/home/headlines/New_Drug_May_Prevent_Breast_Cancer_12...

The New York Times

June 5
Drugs Show Promise Slowing Advanced Melanoma - By Andrew Pollack
Two new drugs have been found to prolong the lives of people with advanced melanoma, representing what researchers say is notable progress against the deadly skin cancer after decades of futility. The drugs do not cure melanoma, except perhaps in rare cases. But experts said the drugs might add two to several months to the expected lifespans of people with advanced melanoma. Anna C. Pavlick, DO, is quoted.
- Anna C. Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and the Department of Medicine, Division of Medical Oncology
Read more: http://www.nytimes.com/2011/06/06/health/research/06melanoma.html?emc=eta1

The Skin Cancer Foundation Journal

Volume 12, 2011
The Evolution of Mohs Micrographic Surgery: The Single Most Effective Skin Cancer Treatment - By Perry Robins, MD, with Tobechi L. Ebede, MD, and Elizabeth K. Hale, MD
Today a great variety of therapies exist for the treatment of skin cancers, from topical medications, and cryosurgery to lasers, however, Mohs micrographic surgery is currently the most precise, a tissue-sparing method for the treatment of basal cell and squamous cell carcinomas which is the most common cancers in the United States.
- Elizabeth K. Hale, MD, clinical associate professor, Ronald O. Perelman Department of Dermatology
- Perry Robins, MD, professor emeritus, Ronald O. Perelman Department of Dermatology
- Tobechi L. Ebede, MD, fellow, Ronald O. Perelman Department of Dermatology
Read more: http://digitaleditions.sheridan.com/publication/?i=70417&p=64

The Journal of the American Medical Association

June 4
KIT as a Therapeutic Target in Metastatic Melanoma
Study author Anna Pavlick, DO, along with others, found that among patients with advanced melanoma harboring KIT alterations, treatment with imatinib mesylate results in significant clinical responses in a subset of patients. Responses may be limited to tumors harboring KIT alterations of proven functional relevance.
-Anna C. Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and the Department of Medicine, Division of Medical Oncology
Read more: http://jama.ama-assn.org/content/305/22/2327.short

Daylife.com

June 1
Mark Philips, MD, Awarded 2011 BioAccelerate NYC Prize for Cancer Drug Discovery Research at NYU Cancer Institute
Mark Philips, MD, is a 2011 NYC BioAccelerate prize recipient and will receive $250,000 from the New York City Investment Fund, which will be used to transform his research of K-Ras into commercial cancer treatment drugs.
- Mark R. Philips, MD, professor, Departments of Medicine, Cell Biology, and Pharmacology, Division of Rheumatology
Read more: http://www.daylife.com/quote/02li0J9fPh9Rj?__site=daylife&q=Philips

May 2011

Your News Now

May 29
Healthy Living: Sunscreens – By Kafi Drexel
Jennifer Stein, MD, PhD, is featured in segment providing information about sun care options individuals should consider using in preparation for the approaching summer season.
- Jennifer Stein, MD, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
View segment: ynn.com

BioPortfolio

May 26
Primordial Providing Services to Three Healthcare Organizations for Radiation Dosage Monitoring and Reporting – By Admin
Primordial, a leading vendor of applications for the medical imaging market, announced three US healthcare organizations licensed and deployed solutions for radiation dosage monitoring and management: NYU Langone Medical Center, Cleveland Clinic, and Christiana Care Health System.
- NYU Langone Medical Center
More: bioportfolio.com, pr-inside.com

Todaysthv.com

May 23
Survival Rate of Prostate Cancer Higher With Prostatectomy - By Stefanie Bryant
A new study says men under 75 years old with early stage prostate cancer treated with surgery had a 25% reduction in death rate and were 60% less likely to have the cancer metastasize or spread to other parts of the body. Herbert Lepor, MD, is featured.
- Herbert Lepor, MD, professor and Martin Spatz Chair, Department of Urology
More: todaysthv.com

Women's Health Magazine

Also appeared on Care2
May 20
10 New SPF Secrets - By Kimberly Goad
The Environmental Working Group, a nonprofit research organization based in Washington, D.C., reviewed nearly 1,400 sunscreens in 2010 and found only 8 percent made the grade in terms of preventing skin cancer and signs of aging. Robert J. Friedman, MD, is quoted.
- Robert J. Friedman, MD, clinical professor, Ronald O. Perelman Department of Dermatology
Read more: womenshealthmag.com, care2.com

MedicineNet.com

May 17
GPs Lack Accuracy in Spotting Skin Cancers: Study - By Maureen Salamon
A new study finds when general doctors refer patients to a specialist to investigate a suspicious skin lesion, it's more often another lesion that turns out to be cancerous. The findings suggest non-dermatologists might benefit from increased education on skin cancer detection. Dr. Darrell S. Rigel is quoted.
- Darrell S. Rigel MD, clinical professor, Ronald O. Perelman Department of Dermatology
More: medicinenet.com

ABC News Radio

Also appeared on Topix.com
May 16
When's the Best Time to Check for Skin Cancer? - By Joshua Cohan
Dr. Jennifer Stein is featured and discusses the best time to check for skin cancer. Some suspect winter is the best time because the skin tends to be paler and growths are more visible.
- Jennifer Stein, MD, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
More: abcnewsradioonline.com, topix.com

Medical News TODAY

May 16
Joint Study by Rosetta Genomics and NYU Langone Medical Center Identifies Potential MicroRNA Drug Target for Mesothelioma
The results of a joint study with NYU Langone Medical Center and Rosetta Genomics were published in the online issue of The Journal of Biological Chemistry on May 12. The study "Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma," demonstrates the potential of miR-31 to be used for the development of new therapies against mesothelioma and other cancers.
- NYU Langone Medical Center
More: medicalnewstoday.com

The New York Times

(Also appeared on GoUpstate.com)
Arc of Life and Love, Unbent by Treatment
May 16
Article shows Gavin Snow, 31, who is diagnosed with advanced stages of melanoma cancer, receiving treatment at NYU Langone Medical Center in photographs included in article.
- NYU Langone Medical Center
More: nytimes.com, goupstate.com

HealthDay

(Also appeared on U.S. News & World Report, iVillage Health, Drugs.com)
May 16
GPs Lack Accuracy in Spotting Skin Cancers: Study - By Maureen Salamon
A new study finds when general doctors refer patients to a specialist to investigate a suspicious skin lesion, it's more often another lesion that turns out to be cancerous. The findings suggest non-dermatologists might benefit from increased education on skin cancer detection. Dr. Darrell S. Rigel is quoted.
- Darrell S. Rigel MD, clinical professor, Department of Dermatology
More: healthday.com, usnews.com, ivillage.com drugs.com

Indiatimes.com

May 14
NYU Langone Medical Center Receives Two Grants From the Avon Foundation for Women
NYU Langone Medical Center received two high impact grants totaling $2.375 million from the Avon Foundation for Women to support breast cancer research in premenopausal women and help improve accessibility to treatment for underserved women with breast cancer.
- William L. Carroll, the Julie and Edward J. Minskoff Professor of Pediatrics, Departments of Pediatrics and Pathology
More: indiatimes.com

NY Social Diary

May 13
Spring Bloomers – Photographs by Ann Watt
NYU Langone Medical Center raised over $9.7 million at its annual Violet Ball on May 4, 2011 at Cipriani. Fiona and Stanley Druckenmiller were this year’s honorees, in recognition for their longstanding support of the Medical Center.
- Robert I. Grossman, MD, Dean and CEO
- Kenneth G. Langone, chair, Board of Trustees
- John Sexton, PhD, JD, president, New York University
- Fiona Druckenmiller, trustee
- Richard W. Tsien, DPhil, the Druckenmiller Professor of Neuroscience, Department of Neuroscience
- Nader Mherabi, senior vice president and vice dean, Chief Information Officer (Interim), Departments of Application and Administration
- Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
- Deborah Loeb Bohren, vice president, Department of Communications and Public Affairs, and trustees Alice Tisch, Sylvia Hassenfeld, Larry and Lori Fink, Jacqueline Harris Hochberg, Helen Kimmel, Sir Deryck Maughan, Martin Lipton, Gary Cohn, Edward Meyer, Sam Sutton
More: newyorksocialdiary.com

Leukemia & Lymphoma Society

(Also appeared in Medical News Today, e! Science News, BiomedME.com)
May 12
Study Reveals Origins of a Cancer Affecting the Blood and Bone Marrow
A new study by the NYU Cancer Institute sheds light on the origins of myeloid leukemia, a type of blood cancer that affects children and adults. Researchers discovered novel mutations in an intracellular communication pathway called Notch led to the cancer. The study is published in the May 12, 2011 issue of the journal Nature. Dr. Iannis Aifantis is quoted.
- Iannis Aifantis, PhD, associate professor, Department of Pathology
- NYU Cancer Institute
More: communications.med.nyu.edu

ScienceDaily

(Also appeared on OrganizedWisdom.com)
May 11
Study Reveals Origins of a Cancer Affecting the Blood and Bone Marrow
A new study by the NYU Cancer Institute sheds light on the origins of myeloid leukemia, a type of blood cancer that affects children and adults. Researchers discovered novel mutations in an intracellular communication pathway called Notch led to the cancer. The study is published in the May 12, 2011 issue of the journal Nature. Dr. Iannis Aifantis is quoted.
- Iannis Aifantis, PhD, associate professor, Department of Pathology
- NYU Cancer Institute
More: communications.med.nyu.edu

U.S. News & World Report

(Also appeared on Wired.com)
May 11
Idling Jets Pollute More than Thought – Sunlight Turns Oily Emissions into Potentially Toxic Particles - By Janet Raloff
Airports can pose a far bigger threat to local air than previously recognized due to the transformative power of sunlight. In the first on-tarmac measurements of their kind, researchers have shown oil droplets spewed by idling jet engines can turn into particles tiny enough to readily penetrate the lungs and brain. George Thurston is quoted.
- George D. Thurston, ScD, professor, Department of Environmental Medicine
More: usnews.com, wired.com

Insciences.org

May 11
Study Reveals Origins of a Cancer Affecting the Blood and Bone Marrow
A new study by the NYU Cancer Institute sheds light on the origins of myeloid leukemia, a type of blood cancer that affects children and adults. Researchers discovered novel mutations in an intracellular communication pathway called Notch led to the cancer. The study is published in the May 12, 2011 issue of the journal Nature. Dr. Iannis Aifantis is quoted.
- Iannis Aifantis, PhD, associate professor, Department of Pathology
- NYU Cancer Institute
More: communications.med.nyu.edu

NY1

May 10
Know Your Sunscreen Options This Season – By Kafi Drexel
Dr. Jennifer Stein is featured in segment providing information about sun care options individuals should consider using in preparation for the approaching summer season. Dermatologists recommend using sunscreen with UVB and UVB protection with an SPF of 30 or above.
- Jennifer Stein, MD, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
More: View NY1 segment

ABC News

May 10
Hospitals, Medical Centers Offering Meditation and More
Post highlights NYU Langone Medical Center as offering meditation, yoga and more to patients. Health care providers are increasingly suggesting patients look to meditation and other integrative techniques to improve their health, according to a report released Monday by Harvard Medical School and published in the Archives of Internal Medicine.
- NYU Langone Medical Center
- NYU Langone Medical Center, NYU Cancer Institute
- NYU Langone Medical Center, Hassenfeld Children's Cancer Center
- NYU Langone Medical Center, Fertility Center
Read more and view segment: abcnews.go.com

ScienceNews

May 10
Idling Jets Pollute More than Thought -- Sunlight Turns Oily Emissions into Potentially Toxic Particles - By Janet Raloff
Airports can pose a far bigger threat to local air than previously recognized due to the transformative power of sunlight. In the first on-tarmac measurements of their kind, researchers have shown that oil droplets spewed by idling jet engines can turn into particles tiny enough to readily penetrate the lungs and brain. George Thurston is quoted.
- George D. Thurston, ScD, professor, Department of Environmental Medicine
More: sciencenews.org

CBS 2 News

May 9
New Prostate Cancer Study - By Max Gomez, MD
Dr. Herbert Lepor is featured in segment about prostate cancer. A new study says men treated with surgery had a 25% reduction in death rate and were 60% less likely to have the cancer metastasize or spread to other parts of the body for men under 75 years old with early stage prostate cancer. The study shows there is significant benefit as far as overall survival if radical prostatectomy is chosen.
- Herbert Lepor, MD, professor and Martin Spatz Chair, Department of Urology, professor, Department of Pharmacology
Read more and view segment: newyork.cbslocal.com

Men's Health

May 6
This Man Will Get Skin Cancer
Jennifer Stein, MD, PhD, is featured and says individuals with a lot of moles need to look out for new moles, as well as get regular skin exams.
- Jennifer Stein, MD, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
Read more: menshealth.com

Medical News Today

May 5, 2011
GEN Reports On Novel Noninvasive Tests for Early Cancer Detection
At the AACR meeting Dr. Harvey Pass discussed his group's experience working in collaboration with SomaLogic to develop an aptamer-based diagnostic to detect malignant mesothelioma in asbestos-exposed individuals.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
More: medicalnewstoday.com

ABCNews.com

May 5, 2011
Montana Dad Gives Cancer-Stricken Boy Marijuana Behind Doctor's Back - By Susan Donaldson James
A father's decision to give his 3 year old son with cancer medical marijuana--behind the doctors' backs-- to help with pain and nausea has raised serious questions about a parent's role in medical treatment. Dr. Linda Granowetter comments.
- Linda Granowetter, MD, professor, Department of Pediatrics, Division of Hematology
More: abcnews.go.com

CBS Newspath

May 4
Prostate Cancer Study
Dr. Herbert Lepor commented on a new study in the New England Journal of Medicine that found if you were treated with prostate cancer surgery you had a 25% reduction in your death rate and were 60% less likely to have the cancer metastasize or spread to other parts of the body. The study shows there is significant benefit as far as overall survival if radical prostatectomy is chosen.
- Herbert Lepor, MD, professor and Martin Spatz Chair, Department of Urology, professor, Department of Pharmacology
More: wusa9.com, ozarksfirst.com

Pocatello Parents.com

May 4
Pregnant With Cancer, Mom Makes Gut-Wrenching Decision - By Lindy Washburn
Article covers the story of Sheri Quattrocchi who was 13 weeks pregnant when she was diagnosed with metastatic melanoma, an advanced form of the deadliest type of skin cancer, which she thought she'd beaten two years earlier. Dr. Anna Pavlick is quoted.
- Anna C. Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and the Department of Medicine, Division of Medical Oncology
More: pocatelloparents.com

Genetic Engineering & Biotechnology News (GEN)

(Also appeared on DailyIndia.com, Andhranews.net, BigNewsNetwork.com, ThaindianNews.com, MedicalNewsToday.com, RedOrbit.com, ScienceDaily.com, Bio-Medicine.com, ScienceCodex.com, HealthCanal.com)
May 4
Novel Non-Invasive Tests Could Help in Early Detection of Cancer
At the 2011 annual meeting of the American Association of Cancer Researchers (AACR) researchers demonstrated they are intensifying their efforts to identify and validate various types of molecular biomarkers for solid tumors that are detectable in blood and urine. Dr. Harvey Pass is quoted about his work to develop an aptamer-based diagnostic to detect malignant mesothelioma in asbestos-exposed individuals.
-Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
More: genengnews.com

U.S. News & World Report

(Also appeared on Yahoo! News)
May 3
Health Buzz: Indoor Tanning Popular Among Teens Despite Risks - By Angela Haupt
Studies have found people who engage in indoor tanning increase their risk of developing the deadly skin cancer melanoma by 75 percent. According to survey findings released by the American Academy of Dermatology, 32 percent of young women polled still said they had used a tanning bed within the past year, and 25 percent repeated the experience on a weekly basis. Dr. Jennifer Stein is featured and suggests ways to minimize wrinkles and cancer risks.
- Jennifer Stein, MD, PhD, assistant professor, Ronald O. Perelman Department of Dermatology
More: health.usnews.com, news.yahoo.com

CBS Newspath

Also appeared on Big Country
May 2
Fewer Women in Their 40's are Getting Mammograms - By Sandra Hughes
Dr. Freya Schnabel is featured, commenting on new research that suggests fewer women in their 40s are getting mammograms, a trend that may have been accentuated after a government panel recommended women do not need a regular mammogram until they are 50 years old.
- Freya R. Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
More: View CBS Newspath segment, bigcountryhomepage.com

April 2011

Crain's New York Business

April 28
Hospitals Turn to Private Funding for Screenings
The NYU School of Medicine breast cancer screening program for Arab-American immigrants is receiving financial assistance from the greater New York City chapter of the Susan G. Komen Foundation to help alleviate the impact of state and city funding cuts.
- NYU School of Medicine
More: crainsnewyork.com

HuffPost Health

(Also appeared on The Times of India, Topix.com)
April 24
Malignant Melanoma: The Silent Killer - By Robert Tornambe, MD
Article about skin cancer says melanoma accounts for just 5 percent of all skin cancers. However, melanoma is responsible for nearly all of the deaths from skin cancer and it is the most common form of cancer found in people 25 to 29 years old. Dr. Philip Orbuch is quoted, suggesting ways to prevent and detect melanoma early on.
- Philip Orbuch, MD, clinical associate professor, Department of Dermatology
More: huffingtonpost.com

PHYSORG.com

April 20
NYU Langone Medical Center Awarded $4.5 Million for Breast Cancer Research
The U.S. Department of Defense (DOD) Breast Cancer Research Program (BCRP) of the Office of the Congressionally Directed Medical Research Programs has awarded Dr. Silvia Formenti a $4.5 million Multi-Team Award to conduct novel breast cancer research.
- Silvia C. Formenti, MD, the Sandra and Edward H. Meyer Professor of Radiation Oncology and chair, Department of Radiation Oncology
More: physorg.com

NY Daily News

(Also appeared on The Village Voice, Oral Cancer News)
April 18
Oral Sex, HPV Puts Non-Smoking Men at Highest Risk for Oral Cancer: What are the Facts? - By Lindsay Goldwert
Doctors say the cases of oral cancer resulting from exposure to the Human papillomavirus (HPV)-16 strain of the virus are hitting epidemic proportions in the U.S., effecting mostly white, male, non-smokers in their late 30s and early 40s. Dr. Mark D. DeLacure is quoted.
- Mark D. DeLacure, MD, associate professor, Departments of Otolaryngology, Surgery, and Plastic Surgery, Division of Head and Neck Surgery and Oncology
More: nydailynews.com

MedPage Today

(Also appeared on MedIndia.com)
April 15
Lab Notes: New Tumor Targets
Research round-up features work by Dr. Ramanuj DasGupta. Using RNA interference-technology and high-throughput chemical genetic screening, Dr.DasGupta and colleagues have scanned nearly 15,000 compounds for their effect on the Wnt signaling pathway, which is involved in the growth of tumors. Dr.DasGupta is quoted.
- Ramanuj DasGupta, PhD, assistant professor, Department of Pharmacology
More: medpagetoday.com, medindia.net

Ecancer.tv

(Also appeared on blinkx.com)
April 15
Protein Test Detects Early-Stage, Asbestos-Related Pulmonary Cancer
Dr. Harvey Pass speaks about a novel biomarker test that is believed to be the most accurate yet in detecting proteins secreted from tumors caused by exposure to asbestos.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
More: ecancermedicalscience.com, blinkx.com

U.S. News and World Report

(Also appeared on HealthDay, Businessweek,Yahoo! News,Womenshealth.gov, ThirdAge.com, iVillage Health, Bio-Medicine.org, Healthline.com)
April 15
Blood Test May Help Predict Spread of Melanoma - By HealthDay
A new study suggests a blood test could be used to predict the risk of cancer spreading, or metastasizing, in people who have melanoma skin cancer. Dr. Iman Osman comments on findings.
- Iman Osman, MD, associate professor, Departments of Medicine, Dermatology and Urology
More: health.usnews.com

ABC World News

April 14
Shortage of Leukemia Drug Forcing Hospitals to Turn Some Patients Away - By Kim Carollo
NYU Langone Medical Center is quoted in article regarding a recent critical shortage of cytarabine, a leukemia drug. ABC News heard from dozens of medical centers on reported shortages of cytarabine. While some hospitals reported no shortages, others said supplies of the drug were running critically low-and in some places, shortages have even affected patient care.
- NYU Langone Medical Center
More: abcnews.go.com

PHYSORG.com

(Also appeared on e! Science News, HealthNewsDigest.com, Sciencecodex.com, Proceedings of the National Academy of Sciences)
April 13
Small Molecules Inhibit Growth of Human Tumor Cells
Researchers from the Cancer Institute have identified three novel small molecules that interrupt a crucial cellular communication pathway that regulates many aspects of development and cancer. The finding could provide the basis for innovative therapies for colorectal cancer and other diseases associated with aberrations in this pathway. Dr. Ramanuj DasGupta is quoted.
- Ramanuj DasGupta, PhD, assistant professor, Department of Pharmacology
More: physorg.com

CUNY TV

April 10, 2011
Study With the Best Special: I'm Not Alone
Documentary explores how CUNY, the nation's largest urban public university, has been affected by breast cancer through personal stories of CUNY staff impacted by the disease. CUNY TV producer Sara Porath, a patient at the NYU Cancer Institute, was profiled.
- NYU Cancer Institute
More: View segment

ScienceDaily.com

April 8
Acquisition of Robotic Technology Leads to Increased Rates of Prostate Cancer Surgery
Article highlights a study conducted by NYU Langone Medical Center that shows when hospitals acquire surgical robotic technology, men in that region are more likely to have prostate cancer surgery. Dr. Danil Makarov is quoted.
- Danil V. Makarov, MD, MHS, assistant professor, Department of Urology, assistant professor of Health Policy at The Robert F. Wagner Graduate School of Public Service
More: sciencemagnews.com

Star Global Tribune

April 8
Protein Test Detects Early-Stage, Asbestos-Related Pulmonary Cancer
A study conducted by researchers at NYU Langone Medical Center investigates a novel biomarker test believed to be the most accurate method in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the American Association for Cancer Research 102nd Annual Meeting 2011, held April 2-6. Dr. Harvey I. Pass is quoted.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
More: starglobaltribune.com

MedIndia

(Also appeared on BioPortfolio, AboutMesothelioma.net, Asbestos.net)
April 8
New Protein Test to Detect Pulmonary Cancer - By Sheela Philomena
A study conducted by researchers at NYU Langone Medical Center investigates a novel biomarker test believed to be the most accurate method in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the American Association for Cancer Research 102nd Annual Meeting 2011, held April 2-6. Dr. Harvey I. Pass is quoted.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
More: medindia.net

USA Today

(Also Appeared on RX Journals)
April 7
New Research Findings Presented By NYU Cancer Institute Experts at the AACR 102nd Annual Meeting 2011
Article highlights research conducted by experts at the Cancer Institute at NYU Langone Medical Center presented at the American Association for Cancer Research 102nd Annual Meeting 2011, held April 2-6.
- NYU Cancer Institute
More: content.usatoday.com, rxjournals.com

Medical News Today

(Also appeared on Red Orbit, e! Science News, Biocompare.com)
April 7
New Research Findings Presented By NYU Cancer Institute Experts at the AACR 102nd Annual Meeting 2011
Article highlights research conducted by experts at the Cancer Institute at NYU Langone Medical Center presented at the American Association for Cancer Research 102nd Annual Meeting 2011, held April 2-6.
- NYU Cancer Institute
More: medicalnewstoday.com, redorbit.com

Drugs.com

April 6
SEATTLE GENETICS: Reports Brentuximab Vedotin (SGN-35) Data at EBMT Annual Meeting - By Peggy Pinkston
Seattle Genetics, Inc. today announced patients with Hodgkin lymphoma receiving brentuximab vedotin (SGN-35) relapsed following allogeneic transplant. Data was presented in an oral session at the European Group for Blood and Marrow Transplantation (EBMT) Annual Meeting in Paris, France. Dr. Owen A. O'Connor is quoted.
- Owen A. O'Connor, M.D, PhD, professor, Departments of Medicine and Pharmacology and chief, Division of Hematologic Malignancies and Medical Oncology
More: drugs.com

News Medical

(Also appeared on Medical News Today)
April 6
Pancreatic Cancer Action Network, AACR Honor NYU School of Medicine's Scientist with Fellowship
Article announces Dr. Cosimo Commisso is the 2011 recipient of The Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship, a one-year grant designed to support pancreatic cancer research. Dr. Commisso was honored at the American Association for Cancer Research 102nd Annual Meeting 2011, held April 2-6, in Orlando, Florida.
- Cosimo Commisso, PhD, postdoctoral fellow, Department of Biochemistry
More: news-medical.net, medicalnewstoday.com

Sciencenewsline.com

(Also appeared on Zimbio.com)
April 5
New Test Detects Early-Stage Asbestos-Related Pulmonary Cancer
A study conducted by researchers at NYU Langone Medical Center investigates a novel biomarker test believed to be the most accurate method in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the American Association for Cancer Research 102nd Annual Meeting 2011, held April 2-6. Dr. Harvey I. Pass is quoted.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
More: sciencenewsline.com, zimbio.com

Yahoo! Finance

April 5
Maven Semantic: Analgesia Research Database - By Bryan McManmon
NYU Langone Medical Center is listed as a leading organization in Analgesia research by Maven Semantic. Mavin Semantic's new skin cancer research database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.
- NYU Langone Medical Center
More: finance.yahoo.com

Medical News Today

(Also appeared on Sciencecodex.com, Bio-Medicine, iStockAnalyst.com)
April 5
Protein Test Detects Early-Stage, Asbestos-Related Pulmonary Cancer
A study conducted by researchers at NYU Langone Medical Center investigates a novel biomarker test believed to be the most accurate method in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the American Association for Cancer Research 102nd Annual Meeting 2011, held April 2-6. Dr. Harvey I. Pass is quoted.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
More: medicalnewstoday.com, sciencecodex.com, bio-medicine.org, istockanalyst.com

PHYSORG.com

April 4
NYU School of Medicine Researcher Receives Pancreatic Cancer Action Network- American Association for Cancer Research Fellowship
Dr. Cosimo Commisso is the 2011 recipient of The Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship, a one-year grant designed to support pancreatic cancer research. Dr. Commisso was honored at the American Association for Cancer Research 102nd Annual Meeting 2011.
- Cosimo Commisso, PhD, postdoctoral fellow, Department of Biochemistry
More: physorg.com

BioPortfolio

(Also appeared on NewsBlaze.com)
April 4
NYU School of Medicine Researcher Receives Pancreatic Cancer Action Network- American Association for Cancer Research Fellowship
Dr. Cosimo Commisso is the 2011 recipient of The Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship, a one-year grant designed to support pancreatic cancer research. Dr. Commisso was honored at the American Association for Cancer Research 102nd Annual Meeting 2011, held April 2-6, in Orlando, Florida.
- Cosimo Commisso, PhD, postdoctoral fellow, Department of Biochemistry
More: bioportfolio.com

Physorg.com

April 4
Protein Test Detects Early-Stage, Asbestos-Related Pulmonary Cancer
Researchers investigating a novel biomarker test believe it is the most accurate method in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the AACR 102nd Annual Meeting 2011, held April 2-6. Dr. Harvey I. Pass is quoted.
- Harvey I. Pass, MD, professor, Departments of Cardiothoracic Surgery and Surgery
More: physorg.com

March 2011

BioPortfolio

(Also appeared on Earthtimes.org, iStockanalyst.com)
March 31
Maven Semantic: Skin Cancer Research Database - Bryan McManmon
NYU Langone Medical center is listed as a leading organization in skin care research by Maven Semantic. Mavin Semantic's new skin cancer research database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.
-NYU Langone Medical Center
More: bioportfolio.com, earthtimes.org, istockanalyst.com

Yahoo! Finance

(Also appeared on Live-pr.com, PR-inside.com)
March 31
Maven Semantic: Skin Cancer Research Database - Bryan McManmon
NYU Langone Medical center is listed as a leading organization in skin care research by Maven Semantic. Mavin Semantic's new skin cancer research database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.
- NYU Langone Medical Center
More: finance.yahoo.com, live-pr.com, pr-inside.com

The Doctor's Channel

March 30
Adjunctive Treatments for Castration Resistant Prostate Cancer
Dr. Anna Ferrari discusses longstanding prostate cancer treatment options in addition to chemotherapy, including antiadrogens and CYP inhibitors.
- Anna Ferrari, MD, professor, Department of Medicine, Division of Oncology
More: thedoctorschannel.com

U.S. News and World Report

(Also appeared on NY Daily News, NY1, WNBC)
March 29
NYU Langone Medical Center Ranked #2 Hospital in New York
NYU Langone Medical Center is the number two New York hospital in a regional hospital list unveiled by U.S. News & World Report-regional rankings are based on national rankings data. Ranked # 25 in Cancer.
- NYU Langone Medical Center
More: health.usnews.com

MedScape Today

March 29
John Curtin, MD, Elected President of Society of Gynecologic Oncologists - By Fran Lowry
Dr. John P. Curtin has been elected the 43rd President of the Society of Gynecologic Oncologists (SGO).
- John P. Curtin, MD, professor and director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology
More: medscape.com

U.S. News and World Report

(Also appeared on Yahoo!)
March 28
Health Buzz: FDA Approves New Melanoma Drug - By Angela Haupt
Dr. Jennifer Stein comments on a breakthrough cancer medication, Yervoy from Bristol-Myers Squibb Co., that researchers have heralded as the first drug shown to prolong the lives of patients with advanced skin cancer.
- Jennifer Stein, MD, PhD, assistant professor, Department of Dermatology
More: health.usnews.com

Los Angeles Times/Chicago Tribune

(Also appeared on Fox13)
March 28
A Toddler Transplant on 'General Hospital' - By Dr. Marc Siegel
Article questions medical procedure on a recent General Hospital episode, where a toddler who has suffered brain injury and is on life support will donate kidneys to a young girl who has cancer. Dr. William Carroll and Dr. Erik Parker are quoted.
- William Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Departments of Pediatrics and Pathology
-Erik Parker, MD, assistant professor, Department of Neurosurgery
- Marc Siegel, MD, associate professor, Department of Medicine
More: chicagotribune.com

BBM-AM

March 25
FDA Approves New Melanoma Drug
Dr. Anna Pavlick is featured in radio segment and comments on Yervoy, which is a manageable melanoma cancer drug that is given in an out-patient setting.
- Anna Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and NYU Cancer Institute
More: listen to segment

LATimes.com

March 28
A Toddler Transplant on 'General Hospital' - By Marc Siegel
Article questions medical procedure on a recent General Hospital episode, where a toddler who has suffered brain injury and is on life support, will donate kidneys to a young girl who has cancer. Dr. William Carroll is quoted.
- William Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Departments of Pediatrics and Pathology
More: latimes.com

CancerNewsWorld

(Also appeared on Daily Journal)
March 24
NYU Langone Medical Center Physician Honored by the Israel Cancer Research Fund
Dr. Daniel F. Roses was awarded the "Tower of Hope Dr. Daniel G. Miller Excellence in Medicine Award" by the Israel Cancer Research Fund (ICRF) this month.
- Daniel F. Roses, MD, the Jules Leonard Whitehill Professor of Surgery and Oncology, Department of Surgery, Division of Breast Surgery
More: topix.com

Reuters

(Also appeared on Yahoo! News, CNBC.com, LA Times, Baltimore Sun, The Associated Press, Yahoo.com, CBS News, MSNBC, USA Today Your Life-Health, Forbes.com, AOL News, MSNBC Today, National Public Radio, Bloomberg Businessweek, Seattle Times, USA Today News, Bloomberg.com, Alibaba.com, WPIX.com, XE.com, Chicago Tribune)
March 25
UPDATE 3-U.S. FDA Approves Bristol-Myers Melanoma Drug - By Lisa Richwine
Dr. Anna Pavlick comments on a breakthrough cancer medication, Yervoy from Bristol-Myers Squibb Co., that researchers have heralded as the first drug shown to prolong the lives of patients with advanced skin cancer.
- Anna Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and NYU Cancer Institute
More: reuters.com

TIME.com

March 24
Fukushima: The Salt Problem - By Eben Harrell
Article highlights concerns as emergency crews continue to restore cooling to reactor cores in Fukushima. Dr. Mary Helen Barcellos-Hoff comments on low radiation levels and says health effects of the Fukushima crisis should remain minimal.
- Mary Helen Barcellos-Hoff, PhD, professor, Departments of Radiation Oncology and Cell Biology
More: ecocentric.blogs.time.com

eScienceNews

March 24
NYU Langone Medical Center's Dr. John P. Curtin Elected President of the Society of Gynecologic Oncologists
Dr. John P. Curtin has been elected the 43rd President of the Society of Gynecologic Oncologists (SGO). -John P. Curtin, MD, professor and director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology
More: bioportfolio.com

Nurse.com

March 21
New York Notable Nurses
The American Nurses Foundation selected Wendy Budin as a 2010 nursing research scholar for the American Academy of Nursing. Budin was selected for her research on the "Psychosocial Adjustment to Breast Cancer in Unmarried Women" (1994).
-Wendy Budin, RN-BC, PhD, FAAN, director, Nursing Research, Department of Nursing
More: news.nurse.com

Bloomberg

(Also appeared on News telegram.com)
March 22
Bristol-Myers Awaits Approval for Drug's New Cancer Attack
Dr. Anna Pavlick comments on a new skin-cancer drug that is being cleared by the Food and Drug Administration. Ipilimumab would become the first marketed medicine proven to extend survival in metastatic melanoma. The first in a new class of immune-boosting medicines to treat an array of tumors, Ipilimumab removes molecular brakes that prevent immune system cells from attacking cancer instead of directly destroying tumor cells or disrupting their ability to grow like most cancer drugs. Dr. Anna Pavlick is quoted.
- Anna Pavlick, DO, associate professor, Ronald O. Perelman Department of Dermatology and NYU Cancer Institute
More: bloomberg.com

The Doctor's Channel.com

March 18
Radical Prostatectomy as a Treatment for Prostate Cancer
Dr. Anna Ferrari discusses how radical prostatectomy can provide a definitive cure in many cases of prostate cancer. Advances in surgical techniques and the use of robotics are leading to less invasive surgeries with better outcomes for patients, including reduced impotence and incontinence.
- Anna Ferrari, MD, professor, Department of Medicine, Division of Oncology
More: thedoctorschannel.com

Yale Medical Group

March 18
Needle Biopsies for Breast Lesions Recommended over Surgical
Doctors are choosing a more invasive surgical biopsy over the preferred needle biopsy procedure. Florida researchers found that although the rate of surgical biopsies should hover around 10 percent, 30 percent of the breast biopsies studied between 2003 and 2008 were done with the more invasive procedure. Dr. Richard L. Shapiro is quoted in article.
- Richard L. Shapiro, associate professor, Department of Surgery, Division of Surgical Oncology
More: yalemedicalgroup.org

Smart Brief

Colorectal Cancer and African-Americans: Don't Be Afraid to Live
Dr. Fritz Francois provides insight on concerns for African-Americans regarding colorectal cancer -- including higher incidence and mortality rates, underutilization of screening, and why the ACG recommends that African-Americans begin screening at 45.
- Fritz Francois, MD, MS, assistant professor, Department of Medicine, assistant dean, Department of Academic Affairs and Diversity
More: smartbrief.com

CutCancer.com

(Also appeared on mattasons.com)
March 15
Hospitals With Robots Do More Prostate Cancer Surgery
Hospitals that buy surgical robots end up performing more prostate cancer operations, suggesting that technology has become a driving force behind decisions about mens cancer care, new research conducted by NYU Langone Medical Center shows. Dr. Danil V. Makarov is quoted.
- Danil V. Makarov, MD, MHS, assistant professor, Department of Urology, assistant professor of Health Policy at The Robert F. Wagner Graduate School of Public Service
More: cutcancer.com

DOTmed News

March 14
Does Owning a Surgical Robot Encourage Prostatectomies? - By Brendon Nafziger
Hospitals that purchase expensive, high-tech surgical robots perform more prostate surgeries, suggesting that availability of the technology could play a role in determining treatment decisions, according to a new study by NYU Langone Medical Center. Dr. Danil V. Makarov is quoted.
- Danil V. Makarov, MD, MHS, assistant professor, Department of Urology, assistant professor of Health Policy at The Robert F. Wagner Graduate School of Public Service
More: dotmed.com

The New York Times

(Also appeared on New News Publisher, Top News Web and Frenchtribune.com)
March 11
Hospitals With Robots Do More Prostate Cancer Surgery - By Tara Parker-Pope
Hospitals that buy surgical robots end up performing more prostate cancer operations, suggesting that technology has become a driving force behind decisions about men's cancer care, new research shows. Dr. Danil V. Makarov is quoted.
- Danil V. Makarov, MD, MHS, assistant professor, Department of Urology, assistant professor of Health Policy at The Robert F. Wagner Graduate School of Public Service
More: well.blogs.nytimes.com

ScienceDaily.com

(Also appeared on Healthcanal.com, Science Blog, Science Daily, Physorg.com, Healing Well, E Science News, Living Websites, Human Health and Science, North Korean Times, New Tech Unbound, Cancer Buzz, Medical Daily, All Voices, Feed My Science, News Medical, RedOrbit, R&D, Bio-Medicine)
March 10
Acquisition of Robotic Technology Leads to Increased Rates of Prostate Cancer Surgery
A new study conducted by NYU Langone Medical Center shows that when hospitals acquire surgical robotic technology, men in that region are more likely to have prostate cancer surgery.
- Danil V. Makarov, MD, MHS, assistant professor, Department of Urology, assistant professor of Health Policy at The Robert F. Wagner Graduate School of Public Service
More: healthcanal.com

Riverhead Local

March 7
Major Oncology Center to Open at Old P.C. Richard Site - By Denise Civiletti
A leading national oncology network, 21st Century Oncology, is coming to Riverhead and is contracted to open a new treatment center at the former P.C. Richard store on Route 58. The firm was selected to develop a proton-beam cancer treatment center in Manhattan, working with leading cancer institutions, including NYU Langone Medical Center.
-NYU Langone Medical Center
More: riverheadlocal.com

New York Social Diary

March 4
Mothers of the Year - By David Patrick Columbia
Yesterday at noontime at the Plaza in the Grand Ballroom, the American Cancer Society of New York held its annual Mother of the Year luncheon, honoring this year's "Mothers": Dr. Freya Schnabel, Professor, Director of Breast Surgery at NYU Langone Medical Center; and Muffie Potter Aston, Professor and Director of Social and Philanthropic Life in New York City.
- Freya Schnabel, MD, professor, Department of Surgery
More: newyorksocialdiary.com

February 2011

NY1

February 28
Haitian Woman Reunites with Family Ahead of Cancer Treatment - With Lewis Dodley
A Haitian woman is brought to New York City to receive emergency cancer treatment, with the family saying it will mostly likely occur at NYU Langone Medical Center
- NYU Langone Medical Center
More: ny1.com

New York Daily News

February 28
Sen. Kirsten Gillibrand Helps Haiti Cancer Patient Get Proper Treatment in New York City - By Lukas I. Alpert
A gravely ill Haitian woman will come to New York for potentially lifesaving cancer treatment after getting a helping hand from Sen. Kirsten Gillibrand, and will likely be treated at NYU Langone Center.
- NYU Langone Medical Center
More: nydailynews.com

Fox 5 News

(Also appeared in UPN 9)
February 25
Doctors on the Cutting Edge Of Medicine - By Brenda Blackmon
Dr. Kathie Ann-Joseph was highlighted by Fox 5 News as one of medicine's most prominent doctors for her major contributions to breast cancer research and treatment.
- Kathie-Ann Joseph, MD, MPH, assistant professor, Department of Surgery

Medicine.Net

(Also appears in KMIR - NBC, Palm Springs. WFTX-TV, Naples, Ft. Meyers, KMTV - Omaha, KMPH - TV, Fresno, WSYM - Fox, Lansing, MI, Science Magazine News, VitaBeat)
February 22
Study Finds Too Many Surgical Breast Biopsies Performed
According to new research, conducted in the state of Florida and reported online in the American Journal of Surgery, far too often, surgical biopsies are being performed on women who have abnormal mammograms instead of less invasive and safer needle biopsies, a new study finds. Richard Shapiro, MD, director of surgical oncology operations at the NYU Cancer Institute and Deborah Axelrod, MD, director of clinical breast surgery and community outreach at the NYU Cancer Institute are quoted in article.
- Deborah M. Axelrod, MD, associate professor, Department of Surgery, Division of Breast Surgery
- Richard L. Shapiro, associate professor, Department of Surgery, Division of Surgical Oncology
More: medicinenet.com, kmir6.com, fox4now.com, kmtv.com, kmph-kfre.com, fox47news.com, sciencemagnews.com, vitabeat.com

UPN 9 News

February 23
Doctors on The Cutting Edge Of Medicine - By Paul Rosenberg
Dr. Kathie Ann-Joseph was highlighted by UPN 9 News as one of medicine's most prominent doctors for her major contributions to breast cancer research and treatment. "My interest is obviously in disparities and patients who are at high risk for recurrence of breast cancer down the road." Dr. Joseph was recently named to Ebony Magazine's "Power 100."
- Kathie-Ann Joseph, MD, MPH, assistant professor, Department of Surgery
More: my9tv.com

US News & World Report.com

February 20
(Articles also appear in MSN Health, Businessweek.com, HealthDay, Drugs.com, Science Magazine News.com, BreastCancerAdvice.com and MedlinePlus)
Study Finds Too Many Surgical Breast Biopsies Performed
According to new research, conducted in the state of Florida and reported online in the American Journal of Surgery, far too often, surgical biopsies are being performed on women who have abnormal mammograms instead of less invasive and safer needle biopsies, a new study finds. Richard Shapiro, MD, director of surgical oncology operations at the NYU Cancer Institute and Deborah Axelrod, MD, director of clinical breast surgery and community outreach at the NYU Cancer Institute are quoted in article.
- Deborah M. Axelrod, MD, associate professor, Department of Surgery, Division of Breast Surgery
- Richard L. Shapiro, associate professor, Department of Surgery, Division of Surgical Oncology
More: healthday.com, usnews.com, msn.com, businessweek.com, drugs.com, sciencemagnews.com, breastcanceradvice.com, nlm.nih.gov, northshorelij.staywellsolutionsonline.com, kroger.staywellsolutionsonline.com, stmaryhealthcare.org, zimbio.com, medbroadcast.com

HealthFinder.gov

(Also appears in RD Magazine and Life Sciences)
February 20, 21
Study Finds Too Many Surgical Breast Biopsies Performed
According to new research, conducted in the state of Florida and reported online in the American Journal of Surgery, far too often, surgical biopsies are being performed on women who have abnormal mammograms instead of less invasive and safer needle biopsies, a new study finds. Richard Shapiro, MD, director of surgical oncology operations at the NYU Cancer Institute and Deborah Axelrod, MD, director of clinical breast surgery and community outreach at the NYU Cancer Institute are quoted in article.
- Deborah M. Axelrod, MD, associate professor, Department of Surgery, Division of Breast Surgery
- Richard L. Shapiro, associate professor, Department of Surgery, Division of Surgical Oncology
More: healthfinder.gov, rdmag.com

AARP

February 18
Few Types of Cancers Have Screening Tests - By Delthia Ricks
For virtually all other cancers, including ovarian and pancreatic - two rare and deadly ones - early detection remains a dream deferred. Efforts have been under way for years to find screenings for both, but the slow pace and high cost of scientific innovation, and the U.S. Food and Drug Administration's rigorous regulatory process, have pushed the possibility well into the future. Dr. Julia Smith, director of the Breast Cancer Screening and Prevention Program at the NYU Cancer Institute in Manhattan is quoted in article.
- Julia A. Smith, MD, PhD, clinical assistant professor, Department of Medicine, Division of Medical Oncology
More: aarp.org

Wall Street Journal

February 17
Hudson River fish Resist PCBs Through Gene Variant - By Associated Press
Most people think of evolution occurring gradually over thousands of years, but apparently no one told the Atlantic tomcod. In just 50 years or so, the Hudson River fish has evolved to become resistant to toxic PCBs that polluted the river, researchers reported Thursday. Their secret is a gene variant. Dr. Isaac Wirgin, an associate professor of environmental medicine at NYU School of Medicine and the study's lead investigator is quoted throughout article.
- Isaac Wirgin, PhD, associate professor, Department of Environmental Medicine
More: wsj.com, sciencecodex.com, biosciencetechnology.com, science20.com, wnyc.org, sciencenews.org, nationalgeographic.com, chron.com, livescience.com, physorg.com, yahoo.com, esciencenews.com

NY1 Noticias

February 10
A New Study about the Treatment of Women with Breast Cancer - Rosarina Bretón
A new study in the Journal of the American Medical Association reveals that the standard practice of removing lymph nodes during breast cancer surgery many not be necessary for all women. Dr. Cristina Checka, a breast surgeon at NYU Langone Medical Center, was interviewed in Spanish about the new study. She says that this study now shows that some women in the population with breast cancer may be able to avoid extensive removal of the lymph node glands.
- Cristina Checka, MD, assistant professor, Department of Surgery
More: ny1noticias.com

Alex's Lemonade (blog)

February 9
Native American Ancestry Linked to Greater Risk of Relapse in Young Leukemia Patients
New research from St. Jude Children's Research Hospital and the Children's Oncology Group ties the genetic variation characteristic of Native American ancestry to higher odds cancer will return and highlights a strategy to ease the racial disparities in survival. Authors on this paper included William Carroll, MD, Julie and Edward J. Minskoff Professor of Pediatrics, Departments of Pediatrics and Pathology.
- William Carroll, MD, Julie and Edward J. Minskoff Professor of Pediatrics, Departments of Pediatrics and Pathology
More: alexslemonade.org

HealthDay

(Also appeared on U.S. News & World Report, Yahoo!News, MensSexHealth.com,CancerIssues.com, iVillage)
February 9
First Look at Prostate Cancer Genome Yields Insights - By Jenifer Goodwin
Genetic sequencing of the entire prostate cancer cell genome revealed never-before-seen changes in DNA that may contribute to tumor growth, new research finds.
- Anna Ferrari, MD, professor, Department of Medicine, Division of Oncology
More: healthday.com, usnews.com, yahoo.com, menssexhealth.com, cancerissues.com, ivillage.com, doctorslounge.com, randomnumbers.us

Women's Health

February 8
Fresh Air, Bad Air: How to Tell the Difference - By Katherine Bowers
If your favorite bike path winds along a busy thoroughfare, or the tennis court you frequent is located near a traffic-clogged intersection, you may be loading your lungs with harmful pollutants in the form of ozone (the main component of smog) and microscopic bits of soot, dust, aerosol, metal, free radicals, and other airborne contaminants. Not only does this toxic assault on your lungs compromise the effectiveness of your workouts, but it can also take a toll on your health.
- George D. Thurston, ScD, professor, Department of Environmental Medicine
More: womenshealthmag.com

CBS 2 New York

February 7
Preventing Cancer - With Max Gomez
Dr. Deborah Axelrod, a breast surgeon at NYU Cancer Center speaks to how people can adopt lifestyle changes to minimize cancer risks.
- Deborah Axelrod, MD, associate professor, Department of Surgery, NYU Cancer Institute
More: newyork.cbslocal.com

CBS News.com

February 2
Prostate Cancer Self-Defense: Nine Deadly Myths
Dr. Herbert Lepor - director of the Smilow Comprehensive Prostate Cancer Center at NYU Langone Medical Center - explodes nine all-too-common misconceptions about prostate cancer.
- Herbert Lepor, MD, professor and Martin Spatz Chair, Department of Urology
More: cbsnews.com

January 2011

The Observer

(Also in The Student NewsPaper of Yeshiva University)
January 31
Panel for Pink: A Discussion about Breast Cancer - By Meirah Shedlo
Dr. Freya Schnabel, Director of Breast Surgery at the NYU Langone Medical Center, served as a panelist at an informal panel discussion held by The Yeshiva University Student Medical Ethics Society and Center for the Jewish Future, to increase awareness about breast cancer and its implications for Jewish women. Dr. Schnabel approached the discussion from a medical and scientific viewpoint.
- Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
More: yuobserver.com

ASCO Post

January 20
A Conversation with Jasmine Zain, MD: The Evolving Role of Stem Cell Transplantation in the Treatment of Blood Cancers - By Jo Cavallo
The ASCO Post talked with Jasmine Zain, MD, Director of the Bone Marrow Transplant Program and Assistant Professor, Division of Hematologic Malignancies and Medical Oncology at NYU Cancer Institute and NYU Langone Medical Center in New York, about how stem cell transplantation is being used both as a front-line treatment in these cancers and as a treatment for relapsed disease.
- Jasmine Zain, MD, assistant professor, Department of Medicine, director of The Rita J. and Stanley H. Kaplan Stem Cell/Bone Marrow Transplant Center
More: ascopost.com

USA Today

January 27
Sean Avery gets nude for skin care - By Tom Weir, USA TODAY
All right, college graduates, here's a question: What's the largest human organ? No, it's not Rex Ryan's mouth. It's your skin, and the New York Rangers winger Sean Avery wants you to take care of it. Avery cares so much, in fact, that he posed nude (with the important parts covered by his hands) for a T-shirt aimed at raising awareness about skin cancer and melanoma. The shirt says "protect your largest organ," and is part of a campaign by the NYU Cancer Institute at NYU Langone Medical Center.
More: usatoday.com, offthebench.nbcsports.com

Associated Press

January 26
FDA Sees Possible Cancer Risk with Breast Implants - By Matt Perrone
Federal health officials said Wednesday they are investigating a possible link between breast implants and a very rare form of cancer, raising new questions about the safety of devices which have been scrutinized for decades. Reports of the cancer among women with breast implants have been reported anecdotally for years, according to Dr. Jasmine Zain. "We've seen it from time to time over the years, but this is the first time the FDA actually looked at all the case reports and made a statement," Zain said.
More: google.com, sawfnews.com, newser.com, cbsnews.com, finance.yahoo.com, aolnews.com, thenewstribune.com, bostonherald.com

ABCNews.com

January 26
FDA Reports Link Between Breast Implants and a Rare Cancer - By lara Salahi
Saline and silicone gel-filled breast implants may be linked to a rare form of blood cancer in some women, according to an announcement made Wednesday by the U.S. Food and Drug Administration. "If you look overall [at the likelihood of ALCL] for women who get these implants it is very, very rare," said Dr. Jasmine Zain, a lymphoma specialist who directs the bone marrow transplant program at the NYU Cancer Institute.
More: abcnews.go.com

Health Day News

January 26
FDA Says Breast Implants Linked to Rare Cancer - By Steven Reinberg
The U.S. Food and Drug Administration said on Wednesday that breast implants may be linked to a heightened risk for a rare cancer, as evidenced in a small but growing number of cases that have been reported in recent years. "The occurrence is very rare, but women have to be very careful," Dr. Jasmine Zain said. "Women should be aware of the risk when deciding whether or not to get breast implants."
More: businessweek.com

Medical News Today

January 25
NYU Langone Medical Center Establishes The Rita J. And Stanley H. Kaplan Stem Cell/Bone Marrow Transplant Center
NYU Langone Medical Center just opened The Rita J. and Stanley H. Kaplan Stem Cell/Bone Marrow Transplant Center (Kaplan Center), dedicated to providing stem cell transplants and comprehensive in-patient and out-patient care for adult and pediatric patients with hematologic cancers. The Center was established with a generous $ 4.2M gift from the Rita J. Kaplan and Stanley H. Kaplan Family Foundation.
More: medicalnewstoday.com, bonecancer.us, stemcelldaily.com, allvoices.com

Newsday

January 24
Few Types of Cancers Have Screening Tests - By Delthia Ricks
The Office of Rare Diseases at the National Institutes of Health considers ovarian cancer a rare affliction because it affects only 25,000 women annually. And, with 16,000 deaths annually, it is one of the most lethal. "We need a test to detect ovarian cancer in large numbers of women that would allow us to intervene in a reasonable amount of time," said Dr. Julia Smith.
More: newsday.com, aarp.org

USA Today

January 22
Breast Cancer Patients With Diabetes May Fare Worse - By Jenifer Goodwin, HealthDay
High levels of insulin may stimulate tumor growth, said Dr. Julia Smith, director of the breast cancer screening and prevention program at NYU Cancer Institute. "I can't conclude that controlling insulin will modify anything about breast cancer, but it tells us we should be looking in those areas and there may be something very important."
More: usatoday.com

ASCO Post

The New York Times

January 20
A Pink-Ribbon Race, Years Long - By Roni Caryn Rabin
Although great strides have been made in the treatment of breast cancer, recent events, including Elizabeth Edwards's death last month and the government's decision to revoke approval of Avastin as a treatment for metastatic breast cancer, have drawn attention to the limits of medical progress - and to the nearly 40,000 patients who die of the disease each year.
- James L. Speyer, MD, director, Clinical Cancer Center
More: nytimes.com

Herald Tribune

January 18
A Pink-Ribbon Race, Years Long - By Roni Caryn Rabin
Although great strides have been made in the treatment of breast cancer, recent events, including Elizabeth Edwards's death last month and the government's decision to ban the drug Avastin as a treatment for metastatic breast cancer, have drawn attention to the limits of medical progress - and to the nearly 40,000 patients who die of the disease each year.
- James L. Speyer, MD, professor, Department of Medicine
More: heraldtribune.com

NY1

January 5
Doctors Shed Light On New Prostate Cancer Treatment - By Kafi Drexel
Doctors at NYU Langone Medical Center are experimenting with light as they look forward to a new, noninvasive way to treat and prevent prostate cancer.
- Samir S. Taneja, MD, The James M. Neissa and Janet Riha Neissa Associate Professor of Urologic Oncology and director of the Division of Urologic Oncology, NYU Cancer Institute
More: ny1.com